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ABSTRACT 
The family of basic-helix-loop-helix-PAS (bHLH-PAS) transcription factors mediate diverse 
cellular processes. These include several important cell fate decisions and cellular responses 
to environmental signals. Molecular and biochemical data indicate that C. elegans ahr-1 and 
aha-1 encode the orthologs of the mammalian aryl hydrocarbon receptor (AHR) and the 
AHR nuclear translocator (ARNT). The C. elegans genome also encodes 3 other bHLH-PAS 
proteins, hif-1, cky-1 and T01D3.2. In this dissertation, I describe molecular, biochemical, 
and genetic analyses of hif-1 and aha-1 and their gene products. C. elegans hif-1 encodes the 
homolog of the mammalian hypoxia-inducible factor a subunit. They form a complex that is 
similar to the mammalian hypoxia-inducible factor, and hif-1 mediates hypoxic responses in 
C. elegans. hif-1 mutants are viable at standard laboratory conditions, but they are unable to 
adapt to hypoxia. Wild-type animals can survive and reproduce in 1% oxygen, but the 
majority of the A -defective animals die in these conditions. We show that HIF-1 :GFP 
expression is induced by hypoxia and is rapidly degraded upon «oxygenation. HIF-1 co-
immunoprecipitates with AHA-1 in vitro. We conclude that the hypoxia-inducible factor 
complex is conserved in C. elegans. To better understand the role of aha-1 in ahr-1 and hif-1 
function, I initiated a genetic analysis of aha-1 function, aha-1 deletion mutants arrest as 
larvae and are defective in feeding. The larval arrest phenotype of aha-1 mutants is much 
more severe than the ahr-1, hif-1 double mutants (which are viable), suggesting that aha-1 
has additional functions. We analyzed the expression patterns of the two remaining bHLH-
PAS genes, T01D3.2 and cky-1. A T01D3.2:GFP reporter is expressed in two intemeurons. 
cky-1 may represent a new bHLH-PAS gene subfamily, and a CKY-1:GFP reporter is 
expressed mainly in the pharynx, the feeding organ of the worm. These data suggested that 
AHA-1 and CKY-1 might interact and function in the pharynx. Several lines of evidence 
support this model. AHA-1 and CKY-1 form a DNA-binding complex in vitro. AHA-1 is 
nuclear localized in the subset of pharyngeal cells that express CKY-1 :GFP. Most 
convincingly, expression of aha-1 from the cky-1 promoter is sufficient to rescue the aha-1 
larval arrest phenotype. We propose that aha-1 has an essential function in the C. elegans 
pharynx. 
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CHAPTER 1 GENERAL INTRODUCTION 
The ability to recognize and respond to developmental and environmental signals is 
essential for all life forms. In many cases, cells respond to extracellular signals by changing 
the activity of particular transcription factors. The resultant changes in gene expression 
control many important cellular responses, such as cell differentiation, proliferation, 
apoptosis and migration. The class of transcription factors containing basic, helix-loop-helix, 
and PAS motifs (bHLH-PAS proteins) regulate an impressive range of cell fate decisions. In 
this dissertation, I study the function of bHLH-PAS proteins in a powerful genetic system, 
the nematode Caenorhabditis elegans. I demonstrate that bHLH-PAS proteins regulate 
cellular responses to hypoxia and have other essential functions during C. elegans 
development. 
LITERATURE REVIEW 
The model organism Caenorhabditis elegans 
The soil nematode Caenorhabditis elegans was originally selected by Sydney 
Brenner in 1963 as a simple genetic model organism to study metazoan development, 
behavior and the function of the nervous system (1). Its short life cycle (3 days at 25°C) and 
the two sexes, hermaphrodite and male, make it an ideal organism for developmental 
genetics. In the laboratory, C. elegans can be cultured conveniently on agar plates with a 
bacterial food source. Mutants can be easily obtained through chemical mutagenesis or 
ionizing radiation. Mutant strains can be frozen and stored. 
The C. elegans life cycle and anatomy are well studied. The hermaphrodite can 
reproduce by self-fertilization or by mating with males. Fertilized eggs undergo 
embryogenesis and hatch as first stage larvae. After a series of four molts and three 
additional larval stages, they become fertile adults. A fully-grown adult is about 1mm long. 
At this stage, hermaphrodites contain 959 somatic nuclei, and males have 1,013 somatic 
nuclei. The complete cell lineage has been determined, and it is essentially invariant (2,3). 
The C. elegans anatomy has been determined by reconstruction of electron micrographs of 
serial sections. This data is complemented by a wealth of subsequent expression studies, and 
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it provides detailed information about every cell's differentiated state. Extensive descriptions 
of the positions of neuronal processes and cell bodies have enabled the construction of 
neuronal connectivity diagrams (4-6). 
A recent milestone for C. elegans research was the release of the essentially 
complete genomic sequence by the C. elegans Sequencing Consortium in 1998 (>99% 
complete today)(7). The worm genome is predicted to contain about 19,000 genes, and over 
17,300 of them have been confirmed as transcribed genes (8). 43% of worm genes have 
apparent human homologs (9). The C. elegans sequence is well annotated (10), and it has 
provided the foundation for the development of C. elegans functional genomics. 
The post-genomic era of C. elegans genetics has been characterized by the increased 
use of reverse genetics, a method in which researchers generate mutations in known or 
predicted gene sequences. The C. elegans Knockout Consortium has generated deletions in 
hundreds of genes using chemical mutagenesis. The deletions were identified and 
subsequently isolated by PCR-based protocols (http://elegans.bcgsc.hc.ca/knockout.shtml. 
11). 
Genome wide studies of gene function have been initiated using RNA-mediated gene 
interference (RNAi). This technique is based on a recent discovery that a gene-specific 
double stranded RNA (dsRNA) can cause the degradation of the corresponding mRNA, 
resulting in loss-of-function phenotypes (12, 13). dsRNA can be delivered into the worm by 
several methods, such as injecting dsRNA into the syncytial gonad of the hermaphrodite 
(13), soaking the worm in the dsRNA solution (14), or feeding the worm bacteria that 
express dsRNA (15). High throughput RNAi studies of worm genes have been reported (16-
19), and the results are entered into Wormbase, the online C. elegans genomic database. 
Initial analysis of the genes on chromosome I indicated that RNAi caused a visible 
phenotypic defect for 13.9% of the genes assayed. Included in this analysis were some genes 
that had been defined by mutational studies. In 31 of 62 cases, the loss-of-function phenotype 
was also revealed by RNAi (16). A modified dsRNA soaking method was used to assay 
2,479 randomly selected genes, and phenotypic abnormalities were observed for 27% of the 
genes targeted (19). Those numbers probably underrepresented the loss-of-function 
phenotypes for the targeted genes, because RNAi is transient. RNAi has also been shown to 
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be relatively ineffective in neurons (20, 21). In general, genes with essential embryonic 
functions are much more likely to be identified by RNAi than those with a postembryonic 
function (22). 
The essentially invariant C. elegans cell lineage can, in theory, be combined with 
genome-wide expression studies to compile and compare cellular transcriptomes. Two 
different methods, gene reporters (GFP or LacZ) and whole-mount in situ hybridization, are 
currently used to analyze gene expression patterns in large-scale studies (http://nematode. 
lab.nig.ac. jp>. This information is further refined and expanded by directed and thorough 
analyses of gene expression in individual laboratories. 
DNA microarrays are used to examine the expression profiles of C. elegans genes at 
specific developmental stages, different growth conditions, or varying genetic backgrounds. 
Affymetrix chips containing oligonucleotides specific for most of the predicted C. elegans 
open reading frames (ORFs) were used to compare gene expression profiles in 8 stages of 
development, from oocytes to 2-week old adults (24). Expression was detected for 56% 
(10,741/18,791) of ORFs analyzed. Using DNA chips containing genomic PGR products 
corresponding to 11,917 C. elegans genes, Reinke et al. (2000) detected expression of 59% 
of the genes assayed. They compared gene expression levels between wild-type and 
germline-defective mutants and identified 1,416 genes that are enriched in the germline. 
Further, they were able to identify oocyte and/or sperm-enriched genes (25). Using similar 
techniques, Jiang et al. (2001) identified 2,171 male- or hermaphrodite-enriched genes (26). 
Additionally, they identified 25 groups of genes whose expression covaried during 
development. Analysis of a much larger data set, microarray data from 553 experiments, 
allowed the identification of 43 groups of genes whose expression covaried under a variety of 
conditions (27). Genes in the same group are regulated in a similar way, suggesting that they 
may be functionally related. One of the limitations of C. elegans microarray experiments is 
that only about 60% of the genes are detected above background level, presumably because 
some genes are expressed at levels that are too low to be measured by the DNA microarrays. 
Another functional genomics project is to generate a protein-protein interaction map 
of all C. elegans predicted ORFs using a genome-wide yeast two-hybrid library. Twenty-
seven genes known to regulate vulval development were used in pilot experiments, and 150 
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interactions were detected (28). This high-throughput method detects approximately half of 
the protein-protein interactions that have been discovered in other studies. Still, it will 
identify a lot of biological interactions, especially when combined with other genome-wide 
studies, such as large scale of phenotypic analysis by RNAi (29). 
All these new functional genomics approaches have already had a great impact on 
how individual researchers design experiments. Both forward and reverse genetic approaches 
are available to study certain developmental processes or the function of a particular gene. 
Traditional positional cloning of a gene identified by mutation is made much easier by both 
the detailed physical map and the genomic sequence. A growing high density single-
nucleotide polymorphism (SNPs) map of C. elegans also aids positional cloning (30, 31). 
When studying the function of a particular gene, testable hypotheses may come from 
functional genomics data, including genetic interactions, coregulation with other genes, 
physical interactions of the gene product, and also the cells in which it expressed. 
basic helix-loop-helix-PAS (bHLH-PAS) proteins 
The changes in gene expression that direct development are controlled by 
transcription factors. The family of transcription factors that contain basic, helix-loop-helix, 
and PAS motifs (bHLH-PAS proteins) regulate an impressive range of cellular differentiation 
events and adaptations to environmental cues (32, 33). 
The PAS domain is a conserved protein motif originally identified in Drosophila 
Period (Per), mammalian aryl hydrocarbon receptor nuclear translocator (ARNT) and 
Drosophila Single-minded (Sim) (34). Per is involved in Drosophila circadian rhythm 
regulation (35). ARNT was first isolated as the co-factor required for aryl hydrocarbon 
receptor (AHR) signaling (36). Sim mediates the development of the Drosophila central 
nervous system (CNS) (34). The PAS domain consists of 250-300 amino acids which 
contains two imperfect repeats, called PAS core domains, A and B. 
Recently the predicted structure of a region containing ARNT PAS B core domain 
was shown to be very similar to the crystallographic structure of the bacteria photoactive 
yellow protein (PYP) (37), the heme domain of the FixL protein (38), and the N-terminal 
domain of the eukaryotic potassium channel HERG (39). In eukaryotes, the PAS domain 
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mediates protein-protein interactions (see below for more detail) and ligand binding, such as 
ligands for the mammalian aryl hydrocarbon receptor (AHR). Eukaryotic PAS domain 
proteins can either directly sense environmental changes (AHR directly binds to its ligands) 
or transduce environmental signals from upstream sensors (hypoxia-inducible factor-la in 
hypoxic responses or Per in circadian rhythm regulation by light). Prokaryotic PAS domain is 
required for cofactor binding in some proteins, such as cofactors for PYP and FixL. PYP is a 
blue-light photosensor, and the blue light is captured by the 4-hydroxycinnamyl chromophore 
within the PAS domain (40). FixL is an oxygen sensor, oxygen directly binds to heme within 
the PAS domain (41). Thus the PAS domain is a multi-functional interaction domain 
conserved from bacteria to human, and the PAS superfamily is proposed to function as 
sensors of environmental or developmental signals (32,33,42). 
With the exception of PER and its homologs, PAS domain-containing proteins that 
have been identified in eukaryotes also contain a basic helix-loop-helix (bHLH) domain at 
the N-terminus. Hence, they are called bHLH-PAS proteins. They are transcription factors 
that function as heterodimers, and heterodimer formation is required for their activities, 
including DNA binding and transactivation. The structure of bHLH-PAS proteins, 
exemplified by ARNT and its homologs, Drosophila Tango and C. elegans AHA-1. is shown 
in Figure 1. The N-terminal basic domain is the DNA binding domain. Each basic domain in 
a dimer recognizes its own half site. Thus the DNA binding specificity of the dimer is 
determined. The helix-loop-helix domain is required for the interaction between two bHLH-
PAS proteins, and it forms the interface between two bHLH-PAS proteins (43). However 
efficient heterodimer formation also requires the PAS domain. Deletion of the ARNT PAS 
domain significantly reduces its ability to dimerize with AHR (43). Furthermore, the PAS 
domains of ARNT and AHR interact directly, even in the absence of the helix-loop-helix 
domain (44). Thus, multiple domains of ARNT are required for the maximal 
heterodimerization with AHR. A truncated AHR containing only the bHLH domain can form 
dimers with multiple proteins containing HLH motifs, but the full-length AHR can not. 
demonstrating that the PAS domain also confers dimerization specificity (45). Besides its 
role in heterodimer formation, the PAS domain of Drosophila Trachealess (Trh) also confers 
target gene specificity. When the Drosophila Single-minded (Sim) PAS domain is exchanged 
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ARNT B 8 
96% r 56% 
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84% 41% 
AHA-1 i A 1 
Figure 1 Structure of ARNT bHLH-PAS protein subfamily. Shown are ARNT. mammalian 
aryl hydrocarbon receptor nuclear translocator (ARNT); Tgo. Drosophila Tango protein; 
AHA-1, C. elegans AHA-1 protein. The nuclear localization signal (NLS) is only found in 
the mammalian ARNT. The conserved basic-helix-loop-helix (bHLH) domains are 
represented by black boxes. The Per-Amt-Sim (PAS) domains are indicated by gray boxes, 
which contain two imperfect repeats called PAS core domains. A and B. The percentage of 
identities of Tgo and AHA-1 in the bHLH and PAS domain, as compared with ARNT. are 
indicated. The transcriptional activation domain (TAD) has been functionally defined in 
ARNT. but not in Tgo or AHA-1. Their protein sequences C-terminal of the PAS domain are 
not conserved. 
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for the Trachealess (Trh) PAS domain, the chimeric protein activates Trh target genes (46). 
AHR deletion studies also revealed that the PAS domain is required for interaction with 
chaperones (Hsp90) or ligands, such as polycyclic aromatic hydrocarbons (PAHs) and dioxin 
(47). As transcription factors, most bHLH-PAS proteins contain transcriptional activation 
domains (TAD) at the C-terminus. However, their C-terminal sequences have little 
similarities. Finally, certain domains are specific for individual bHLH-PAS proteins, such as 
the oxygen-dependent degradation domain (ODD) of the hypoxia-inducible factor a (HIFa) 
(48). 
ARNT proteins are common dimerization partners for multiple bHLH-PAS proteins 
Every DNA-binding dimeric complex of bHLH-PAS proteins that has been described 
thus far contains ARNT or one of its close homologs. Thus, the ARNT subfamily has many 
developmental roles, and the other bHLH-PAS proteins are dedicated to specific regulatory 
functions. Both mammalian ARNT and its Drosophila homolog Tango (Tgo) are able to 
dimerize with multiple bHLH-PAS proteins (Figure 2). 
One of the most extensively studied bHLH-PAS complexes consists of mammalian 
ARNT and AHR. In the absence of ligand, mammalian AHR is primarily cytosolic in a 
complex with heat-shock protein Hsp90 and another chaperone ARA9 (also known as AIPl 
or XAPs). Upon binding to its ligand, AHR translocates into the nucleus where it dissociates 
from the chaperones and binds ARNT. The ARNT/AHR heterodimer binds specific dioxin 
responsive elements (DRE) on the promoter of target genes to regulate transcription. The 
target genes include a battery of xenobiotic metabolizing enzymes (XMEs), including 
cytochrome P450-dependent monooxygenases, such as CYP1A1 and CYP1A2. These 
enzymes are involved in the metabolism of polycyclic aromatic hydrocarbon (PAHs), 
including benezo[a]pyrene. The resulting intermediate metabolites damage DNA, and are, 
therefore, carcinogenic (49). AHR knockout mice are resistant to the carcinogenecity of 
benzo[a]pyrene, demonstrating that AHR is involved in mediating the carcinogenic activity 
of PAHs (50). AHR also has been shown to play important roles in mouse development. Ahr 
null mice generated in three independent laboratories exhibit defects in liver development, 
low weight and poor fertility (51-53). Recently Ahr-/- mice were shown to have defects in 
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Xenobiotic response and 
liver vasculature development 
(Antennal/tarsal development) 
AHR(Ss) 
Circadian rhythm regulation 
(Circadian rhythm regulation) 
Clock(dClk) 
Siml(Sim) 
Neuronal development 
(Neuronal development) 
HIF-la(Sima) 
Hypoxic response 
(Hypoxic response ?) (Trachea development) 
Figure 2 ARNT is the common dimerization partner for multiple bHLH-PAS domain proteins. 
ARNT and its homologs (represented by the black ovals) form dimers with partners dedicated 
to specific cellular or developmental functions. The examples depicted here are the aryl 
hydrocarbon receptor (AHR), circadian rhythm protein Clock, hypoxia-inducible factor-la 
subunit (HIF-la) and mammalian single-minded homolog Siml. ARNT also forms a 
homodimer. Drosophila Tango (Tgo) is the homolog of ARNT. Tgo is able to interact with the 
AHR homolog Spineless-aristapedia (Ss), Single-minded (Sim), Trachealess (Trh) and 
Drosophila HIF-la homolog Similar (Sima). Cycle (Cyc) is the Drosophila Arnt3 homolog. 
Cyc interacts with the Drosophila Clock homolog (dClk). The functions of the dimers are 
indicated. Drosophila homologs and their functions are listed in the parentheses. ? indicate that 
the function either is unknown (ARNT homodimer) or has been suggested, yet still has not 
been proven (Drosophila Sima/Tgo dimer). 
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ovary development (54, 55). Interestingly, PAHs exposure also causes defects in mouse 
ovary development. The toxicity is dependent on the function AHR and its target gene Bax 
(56). AHR is evolutionary conserved (57-59). The Drosophila AHR homolog is encoded by 
the spineless-aristapedia (ss) gene and it interacts with Tgo. Ss plays important roles during 
development, ss mutants have smaller sensory cells (bristles), and the distal leg (tarsus) is 
deleted. Additionally, the distal antenna is transformed into distal leg (59). It has been 
suggested that chemosensation was the ancestral role of AHR/Ss (60). 
The Drosophila bHLH-PAS protein Sim also interacts with Tgo, and the heterodimer 
controls the central nervous system (CNS) midline development (34) (Figure 2). Mammalian 
Siml and Sim2 are able to form similar complexes with ARNT and its close homolog 
ARNT2 (61). Mutant mice lacking Siml and ARNT2 die shortly after birth (62-65). The 
similar defects in the differentiation of secretory neurons (such as paraventricular nucleus, 
PVN) in the hypothalamus suggest that ARNT2 is the likely in vivo dimerization partner for 
Siml during the development of neuroendocrinological cell lineages of the hypothalamus 
and pituitary gland. Interestingly, mouse Sim 1 haploinsufficiency also causes obesity, 
apparently resulting from the decreased number of paraventricular nuclei (PVN) in the 
hypothalamus of affected mice (66). A human balanced translocation that disrupted the Siml 
gene was described recently in a patient with severe early-onset obesity (67). 
ARNT3 (also known as BMAL1, MOP3) is a close homolog of mammalian ARNT, 
and it interacts with another bHLH-PAS protein CLOCK (Figure 2) (68-70). They form the 
positive regulator of the molecular feedback loop in the circadian pacemaker (or clock) (71-
75). Clock and MOP3 loss-of-function mice are arrhythmic (76-78). Drosophila Clock and 
Cycle (MOP3 homolog) form a similar complex, and clock and cycle mutants are also 
arrhythmic (73, 74). 
Drosophila Trachealess (trh) controls the formation of certain tubular structures. In 
trh mutants, epithelial tube-forming cells of the salivary gland, trachea, and filzkorper fail to 
invaginate and remain on the surface of the embryo (79). Trh functions as a heterodimer with 
Tgo. Trh is also regulated by Drosophila Akt. Phosphorylation of S665 by dAkt is required 
for Trh nuclear localization (80). 
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Drosophila tgo mutants are embryonic lethal, and they have defects similar to those 
in sim and trh mutants (81). tgo mutants also have been isolated as enhancers of ss mutations 
(60). These data support the conclusion that Tgo is the common dimerization partner for Ss, 
Sim and Trh in Drosophila (Figure 2). 
Mammalian ARNT can form homodimers in vitro, and the homodimer is able to bind 
to a class B E-box enhancer containing two adjacent ARNT binding half-sites (5-CACGTG) 
(82-84). Additionally, studies in mammalian cell lines have demonstrated that this enhancer 
can direct expression of a reporter gene in an ARNT-dependent manner (82, 83). However 
the in vivo targets and functions of ARNT homodimers are not clear. 
Although mammalian ARNT and its known invertebrate homologs share high 
sequence similarities, their regulation is different. Mammalian ARNT contains a nuclear 
localization sequence (NLS) at its N-terminus (85), and this motif is absent in Drosophila 
Tgo and C. elegans AHA-1 (Figure 1). Current models suggest that ARNT is constitutive^ 
nuclear localized (85). However efficient nuclear localization of Tgo requires the presence of 
their dimerization partners (86). In C. elegans, efficient nuclear localization of AHA-1 in the 
intestinal cells is dependent on the hif-1 function (87). 
Mammalian ARNT is phosphorylated at multiple sites (88). Dephosphorylation of 
ARNT reduces its ability to form heterodimers with AHR in vitro (89). Protein Kinase C 
(PKC)-dependent phosphorylation events positively regulate AHR signaling activity in some 
cell types (89-91). Furthermore, PKC also has been shown to modulate ARNT homodimer 
transactivation activity, as assayed by a reporter containing the class B E-box enhancer (92). 
Hypoxia response pathway 
Molecular cloning of hypoxia-inducible factor-1 
Oxygen homeostasis is critical for the survival of most aerobic life forms because of 
its role in mitochondrial oxidative phosphorylation, which generates ATP. When mammals 
are exposed to hypoxia, cells or tissues must adapt by increasing oxygen supply and reducing 
reliance on oxygen for energy metabolism. Ischemic tissue damage resulting from some of 
the most common human diseases, such as heart attack, stroke and pulmonary hypertension, 
are the leading causes of mortality. Hypoxia also plays important roles in cancer 
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development. Cells in a tumor mass must overcome hypoxia-induced apoptosis (93). They 
also respond to hypoxia by secreting growth factors that induce angiogenesis (94). 
The role of bHLH-PAS proteins in regulating hypoxia response was revealed by the 
molecular identification of hypoxia-inducible factor-1 (HIF-1) (95). Erythropoietin (EPO) is 
a well-characterized hypoxia-inducible gene (96, 97). Oxygen-dependent induction of EPO 
transcription requires a hypoxia-responsive element (HRE, 5-RCGTG) in its promoter (98. 
99). Purification of the factor bound to EPO HRE revealed that HIF-1 contains two subunits. 
HIF-la and HIF-1 (3 (100). The protein sequence of HIF-1 (3 was shown to be identical with 
that of ARNT (95). HIF-la encodes a bHLH-PAS protein that is dedicated to hypoxia 
response (95). Other alpha subunits (mammalian HIF-2a (EPAS1) and HIF-3a) and P 
subunits (ARNT2 and BMALI/MOP3/ARNT3) have also been isolated and they are 
expressed in certain tissues (70, 101-103). 
Model of hypoxia signaling 
HIF-1 activity is regulated by oxygen concentration at multiple levels. During 
normoxia, HIF-la and HIF-1 P are both transcribed, and HIF-la mRNA is up-regulated over 
10-fold in rat brain and lung tissue after hypoxia treatment ( 104, 105). However in cell 
culture experiments, the stability of HIF-la protein is the most important regulatory 
mechanism. The model for HIF-la regulation is illustrated in Figure 3. Translated HIF-la is 
rapidly degraded by an ubiquitin-proteasomal pathway at normoxia (ambient oxygen 
concentration, 21%) (48, 106, 107). Under hypoxic conditions, HIF-la ubiquitination is 
reduced and its degradation is inhibited (106, 108). When oxygen levels are high, a 
conserved proline residue (Pro564) within the oxygen-dependent degradation domain (ODD) 
of HIF-la is hydroxylated (109. 110). The modified HIF-la is recognized by the Von 
Hippel-Lindau tumor suppressor protein (VHL), which is a component of ubiquitin ligase 
complex. VHL binds to the hydroxylated HIF-la and targets it for ubiquitination. 
Polyubiquitinated HIF-la is subsequently degraded by the 26S proteasome (111). The 
enzyme and putative oxygen sensor that modifies the ODD was first identified in C. elegans, 
and it is encoded by the egl-9 gene (112). The mammalian homologs of C. elegans EGL-9 
encode the proly 1-4-hydroxylases that modify HIF-la (112, 113). They are Fe(II)- and 2-
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Low [O2] High [02] 
HIFa 
bHLH-PAS EGL-9/prolyl hydroxylase 
02 
asparaginyl 
hydroxylase 
5'-
CBP/p300 
-RCGTG- target genes 
1VHL mediated ubiquitination 
t degradation by 26S proteasome 
DAO 
ARNT 
Cytosol 
Nucleus 
OH ICBP/p300 
RCGTG- -j target genes 
Transcription ON Transcription OFF 
Figure 3 Model for the regulation of hypoxia-inducible factor (HIF). Under normoxic conditions. 
The HIFa oxygen-dependent degradation domain (ODD) is hydroxylated by prolyl hydroxylases. 
Modified HIFa is recognized by the Von Hippel-Lindau (VHL) tumor suppressor protein, which 
recruits elongins B and C (B. C). Cullin-2 (CUL-2) and RBX1 (R) to ubiquitinate HIFa. 
Polyubiquitinated HIFa is subsequently degraded by the 26S proteasome. Hypoxia inhibits the EGL-
9/prolyl hydroxylase and blocks the degradation of HIFa. Thus, HIFa protein accumulates and 
translocates to the nucleus where it dimerizes with ARNT to form the HIF complex. HIF binds to the 
hypoxic response element (HRE, 5* RCGTG) on the promoter of the target genes. HIFa COOH-
terminal transact!vation domain (CAD) recruits transcriptional coactivators such as CBP/p300 and 
activates the transcription of the target genes. The recruitment of CBP/p300 is also regulated by 
oxygen levels. At normoxia. CAD is hydroxylated by an asparaginyl hydroxylase, which blocks its 
interaction with CBP/p300. Thus, both the stability and the transcriptional activity of HIFa are 
regulated by oxygen levels. 
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oxoglutarate-dependent dioxygenases. Since oxygen is one of the substrates for these 
enzymes, Pro564 is hydroxylated only when oxygen is available. When oxygen is low, HIF-
la is not hydroxylated, and VHL does not target it for degradation. Thus HIF-la 
accumulates and translocates to the nucleus, where it binds to its dimerization partner ARNT 
to form the active HIF-1 complex. HIF-1 binds to hypoxia response elements (HREs) on the 
target gene promoters, and recruits transcriptional cofactors such as CBP/p300 to regulate 
target gene transcription (114). 
The recruitment of CBP/p300 by HIF-1 is also regulated by cellular oxygen levels. 
This is achieved, at least in part, by modifying HIF-la at a second position, an asparagine 
residue (Asn803) within the COOH-terminal transactivation domain (CAD) (115). Asn803 is 
hydroxylated in an oxygen-dependent manner by an unidentified Fe(II)- and 2-oxoglutarate-
dependent dioxygenase. Hydroxylation at Asn803 prevents CBP/p300 recruitment by the 
HIF-la CAD. The two different hydroxylases are speculated to activate HIF-1 at different 
levels in response to the changing oxygen concentration in the environment (116). 
Activated HIF-1 induces the expression of target genes to restore oxygen 
homeostasis. Those genes function at two different levels in mammals. On the systemic level, 
HIF-1 induces the expression of erythropoietin (EPO) and vascular epithelial growth factor 
(VEGF). EPO is a haematopoietic cytokine that increases red blood cell count, thus 
generating more oxygen carriers to increase oxygen supply. VEGF induces the formation of 
new blood vessels to increase the blood flow into the hypoxic tissue. On the cellular level, 
HIF-1 increases the expression of several glycolytic enzyme genes and glucose transporter 
genes, which function to increase glucose uptake and glycolysis. Enhanced cellular 
glycolysis reduces a cell's dependence on oxygen for energy metabolism (mitochondrial 
oxidative phosphorylation requires oxygen to generate ATP. Glycolysis does not). A more 
comprehensive review of HIF-1 target genes and physiological responses to hypoxia can be 
found elsewhere (117, 118). 
Other regulators of HIF-1 
HIF-la degradation is also regulated by p53. p53 binds to HIF-la and recruits the 
ubiquitin-protein ligase MDM2, which targets HIF-la for ubiquitination and degradation 
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(119). Loss of p53 in certain cancer cells enhances the induction of HIF-la and VEGF by 
hypoxia. On the other hand, p53 expression is induced by hypoxia, and the induction is HDF-
la-dependent (120). HIF-la-mediated stabilization of p53 may play a role in hypoxia-
induced apoptosis (93,120). 
Other signal transduction pathways also regulate HIF-1 activity. Like hypoxia, many 
growth factors, including insulin, IGF, EGF, PDGF, heregulin and IL-ip, have been reported 
to induce HIF-1 activity in a variety of cell lines (121-125). In many cases, the induction is 
dependent upon phosphatidyl inositol 3-kinase signaling (PI3K). In some cell lines, elevated 
PI3K pathway activity can facilitate the increase of HIF-la expression at hypoxia. Reduced 
activity of the pathway blocks HIF-la expression (126). Regulation of HIF-1 by growth 
factors appears to be cell type-specific (127). 
Other factors regulate HIF-1 activity by directly binding to HIF-la and affecting the 
heterodimer's DNA binding or transcriptional activity (128, 129). FIH-1 was identified in a 
yeast two-hybrid screen using HIF-la CAD as a bait. FIH-1 binds to HIF-la and VHL. VHL 
recruits hi stone deacetylases to repress HIF-1 transcriptional activity (128). Inhibitory PAS 
(IPAS) is another protein that directly interacts with HIF-la. IPAS is a bHLH-PAS protein 
that lacks the C-terminal transactivation domain. It functions as a dominant negative 
regulator of HIF-1 by binding to HIF-la and interfering with HIF-1 DNA binding. IPAS is 
mainly expressed in the cornea, and it functions to maintain an avascular structure there 
(129). 
Genetic analysis of ARNT and HIFa 
The significance of HIF-1 function is underscored by its essential role during mouse 
development, which is revealed in ARNT and HIF-la knockout experiments. ARNT-
deficient mice die before E10.5 and show defective angiogenesis in the yolk sac, branchial 
arches and embryonic placenta (130, 131). HIF-la knockout mice die at E10.5 and have 
defective vasculature in the myocardial and cephalic tissues (132, 133). The vasculature 
defects of ARNT and HIF-la mutants are very similar to those seen in VEGF mutants, 
providing further evidence that HIF-1 regulates VEGF expression in vivo. However, the role 
of VEGF in causing vascular defects in HIF-la null mice has been questioned. Kotch et al. 
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(134) demonstrate that the VEGF level in HIF-la null mice is increased. They suggest that 
mesenchymal cell death prior to vascular regression in HIF-la null mice may be the cause 
for the defective vascular structure. 
HIF-2a is a close homolog of HIF-la. Both proteins are regulated by hypoxia. 
However, their expression patterns are different. HIF-2a is expressed predominantly in 
epithelial cells (101, 135). More than half of HTF-2a-deficient mice die between E9.5 and 
E13.5 with severe yolk sac vascularization defects (136). Another independently generated 
HIF-2a knockout mice strain dies at midgestation without vascular defects. Thus, the role of 
HIF-2a during vascular development is uncertain. Phenotypic analysis revealed that HIF-2a 
is essential for catecholamine homeostasis (137). Loss of HIF-2a protects ES cells against 
apoptosis during hypoglyceria, but not hypoxia. Further, HIF-2a"'" ES cells fail to induce 
VEGF and other angiogenic factors in response to hypoxia, but they do increase expression 
of glycolytic enzymes (138). 
It has been reported that tumor cells, especially those of solid tumors, are generally 
hypoxic (139). Hypoxia induces vascularization of the tumor, which provides oxygen and 
other nutrients for tumor growth. Tumors derived from ES cells lacking HIF-la do not 
vascularize well (94. 133). ARNT-deficient hepatomas have similar defects (140). 
Surprisingly, in one study, the growth of HIF-la"7" ES tumor xenograph is not retarded, but 
increased. This is explained in part by the failure of tumor cells to undergo hypoxia-mediated 
cell death (94). 
ARNT2 is expressed at high levels in the brain (135). ARNT2 knockout mice die 
shortly after birth because of defective hypothalamus development (62,63). Induction of 
target genes by hypoxia is decreased in cultured ARNT2"'" neurons, suggesting it has partial 
redundancy with ARNT (62). 
Oxygen sensors 
The identification of EGL-9 and the homologous mammalian PHDs (prolyl 
hydroxylase domain-containing genes) provides the first direct link between oxygen 
concentration and HIF activity. The prolyl hydroxylases encoded by these genes require 
oxygen, iron and 2-oxoglutarate as cofactors or substrates. Oxygen is the rate limiting factor 
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for the activities of PHDs (112). This oxygen-sensing mechanism is consistent with the 
finding that HIF-la accumulation is immediate upon exposure to hypoxia (141). Although 
the asparaginyl hydroxylases that modify the CAD have not been identified, biochemical 
analyses indicate that they belong to the same family of Fe(II)- and 2-oxoglutarate-dependent 
dioxygenases (115). Current models presume that oxygen concentration may directly 
regulate their activity. 
Pharmacological studies demonstrate that the level of certain oxygen metabolites, 
such as superoxide or other reactive oxygen species (ROS) also regulate HIF-1 activity in 
tissue culture cells. Mitochondria electron transfer chain (ETC) and NAD(P)H oxidase 
generate most of the ROS and are suspected to be oxygen sensors (reviewed in (118, 142)). It 
is not yet known how many oxygen sensors exist nor how they modify HIF activity. 
Identification of the Fe(II)- and 2-oxoglutarate-dependent dioxygenases as direct 
oxygen sensors provides the protein targets to design specific inhibitors of prolyl or 
asparaginyl hydroxylases. Inhibition of the activities of these enzymes should activate HIF 
and enhance the hypoxic responses, which may reduce the damage caused by many 
ischemia-related diseases. Known inhibitors of the prolyl-4-hydroxylase, such as dimethyl-
oxalylglycine, have been shown to inhibit HIF-la degradation at normoxia ( 109). In a recent 
study, a constitutively active HIF-la (the ODD domain was removed) was expressed in 
mouse epidermis. In the epidermal tissue of these animals, VEGF expression increased 13 
fold, and dermal capillaries increased 66% (143). The hypervascular structure developed in 
those animals did not cause the edema, vascular leakage and inflammation that are common 
in mice overexpressing VEGF. HIF regulates target genes other than VEGF, and together 
they are required for building a better vasculature. On the other hand, HIF-la is 
overexpressed in many human cancers (144). Vascularization and the grade of human 
gliomas are correlated with HIF-la expression level (145). By inhibiting hypoxic responses 
in cancer cells, researchers may be able to limit tumor vascularization and retard tumor 
growth. 
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DISSERTATION ORGANIZATION 
Our research group and others have reported that the C. elegans genome encodes 5 
bHLH-PAS proteins (57, 87, 146). In this dissertation, I initiate functional studies of aha-1 
and hif-1.1 also describe the expression of the other two bHLH-PAS genes, cky-1 and 
T01D3.2. 
In Chapter 1, literature related to the study is reviewed. Major topics include: (i). An 
introduction to the genetic model organism C. elegans, with emphasis on the recent 
advancement in C. elegans functional genomics and its impact on researchers in the worm 
community, (ii). The structure and function of bHLH-PAS transcription factors. The ARNT 
subfamily is used to illustrate the structure and functions of bHLH-PAS proteins. I describe 
the developmental functions of mammalian and Drosophila ARNT homologs, with the 
emphasis on their ability to dimerize with multiple bHLH-PAS proteins, (iii). Hypoxia 
signaling pathway. I describe the current model for hypoxia signaling pathway, also the 
developmental and pathological functions hypoxia-inducible factor-1. 
Chapter 2 is a copy of a research paper published in Proc. Natl. Acad. Sci. USA, 2001. 
98(14):7916-7921. The title is "The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS 
protein that is required for adaptation to hypoxia". Main findings include: (/)- C. elegans 
F38A6.3/hif-1 encodes a homolog of mammalian HIFa. (ii). The expression of C. elegans 
HIF-1 :GFP fusion protein is regulated by oxygen concentrations, (iii). hif-1 mutants are not 
able to adapt to hypoxia, (iv). In vitro expressed HIF-1 and AHA-1 can be co-
immunoprecipitated by an antibody specific to AHA-1. (v). Efficient AHA-1 nuclear 
localization in intestinal cells is dependent upon hif-1 function. Other researchers in the 
laboratory were also involved in this study. Jo Anne Powell-Coffman was the principal 
investigator. Rong Guo was a technician for the laboratory. She generated the AHA-1 
specific monoclonal antibody 10H8. She also built the hif-1 :gfp construct pR19 and the HIF-
1 expression vector pR33. 
In Chapter 3,1 summarize the genetic analyses of aha-1. The title is "An essential 
function for C. elegans bHLH-PAS proteins: Evidence that aha-1 and cky-1 have a role in 
pharyngeal function". The aha-1 mutants are larval lethal with feeding defects. Analyses of 
animals mosaic for aha-1 expression suggest that aha-1 has an essential role in pharynx 
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function. We also demonstrate that C. elegans CKY-1, encoded by C15C8.2, interacts with 
AHA-1 in vitro. CKY-1 may represent a new evolutionary conserved bHLH-PAS subfamily 
that forms heterodimers with ARNT. A model for AHA-l/CKY-l heterodimer function in C. 
elegans pharynx is discussed. Other contributors to this work include Shu Wu, who 
performed the cky-1 RNAi experiments and AHA-1 homodimer DNA binding assays. 
Colleen Cary produced the 6His-AHA-1 fusion protein used to generate the AHA-l-specific 
polyclonal antibody. Jo Anne Powell-Coffman was the principal investigator, and she 
isolated the aha-l(ct383) allele as a postdoctoral fellow in Dr. William Wood's laboratory. 
In Chapter 4,1 summarize and discuss my thesis research, with emphasis on our 
study's impact and contribution to various research fields. In brief, the identification of C. 
elegans hif-1 as the homolog of mammalian HIFa established C. elegans as a simple genetic 
system to study hypoxic response. AHA-1 has multiple functions in C. elegans development, 
including ahr-1, hif-1 (hypoxia) signaling, and at least one other independent essential 
function. C. elegans CKY-1 likely represents a new bHLH-PAS subfamily that interacts with 
members of the ARNT subfamily. 
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CHAPTER 2 
The Caenorhabditis elegans hif-1 gene encodes a bHLH-PAS protein that is 
required for adaptation to hypoxia 
A paper published in 
Proceedings of the National Academy of Sciences of the United States of America' 
Huaqi Jiang2, Rong Guo\ and Jo Anne Powell-Coffman4 
Abstract 
Hypoxia-inducible factor, a heterodimeric transcription complex, regulates cellular 
and systemic responses to low oxygen levels (hypoxia) during normal mammalian 
development or tumor progression. Here, we present evidence that a similar complex 
mediates response to hypoxia in Caenorhabditis elegans. This complex consists of HIF-1 and 
AHA-1, which are encoded by C. elegans homologs of the hypoxia-inducible factor (HIF) a 
and P subunits, respectively, hif-1 mutants exhibit no severe defects under standard 
laboratory conditions, but they are unable to adapt to hypoxia. Although wild-type animals 
can survive and reproduce in 1% oxygen, the majority of hif-1-defective animals die in these 
conditions. We show that the expression of a HIF-l:green fluorescent protein fusion protein 
is induced by hypoxia and is subsequently reduced upon reoxygenation. Both hif-1 and aha-1 
are expressed in most cell types, and the gene products can be coimmunoprecipitated. We 
conclude that the mechanisms of hypoxia signaling are likely conserved among metazoans. 
Additionally, we find that nuclear localization of AHA-1 is disrupted in an hif-1 mutant. This 
finding suggests that heterodimerization may be a prerequisite for efficient nuclear 
translocation of AHA-1. 
1 Reprinted with permission of Proceedings of the National Academy of Sciences of the United States 
of America. 2001,98( 14):7916-7921. 
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Introduction 
Mammals use both systemic and cellular strategies to adapt to decreased oxygen 
levels during normal development and homeostasis. Hypoxic tissues secrete growth factors to 
increase vascularization, and individual cells increase anaerobic metabolism to sustain basic 
cellular functions (1). Hypoxia also plays a central role in tumor biology, as a mass of 
cancerous cells must adapt to hypoxia and induce angiogenesis to grow and metastasize (2). 
The majority of the transcriptional responses to hypoxia are mediated by hypoxia-
inducible factor (HIF) complexes, which consist of a and P subunits. The HIFP subunit is 
also termed ARNT (aryl hydrocarbon receptor nuclear translocator) (3-7). When cellular 
oxygen levels are high, the von Hippel-Lindau tumor suppressor protein (VHL) binds 
directly to the a subunit and targets it for ubiquitination and proteosomal degradation. 
However, in hypoxic conditions, degradation of HIFa is inhibited (8-11). This permits HIFa 
to translocate to the nucleus, dimerize with ARNT, and activate the expression of target 
genes, which act to increase oxygen delivery or implement metabolic adaptation to hypoxia 
(2). Despite intensive study, the mechanisms by which cellular oxygen levels are sensed are 
not well understood. Progress in this field has been limited by the lack of genetic approaches 
to this important problem. 
Widely divergent organisms have the ability to adapt to variable oxygen 
concentrations, which suggests that mechanisms of hypoxic sensing and response may have 
been established early in evolutionary history. Here, we investigate the molecular 
mechanisms of hypoxia response in a powerful genetic model organism, the nematode 
Caenorhabditis elegans. The natural habitat of C. elegans is often hypoxic, and C. elegans 
can adapt to very low environmental oxygen levels (12). We find that the C. elegans hif-1 
and aha-1 gene products form a complex that is similar to the mammalian hypoxia-inducible 
factor, and we find that hif-1 function is required for adaptation to hypoxic conditions. 
Methods 
C. elegans Culture. C. elegans were propagated and maintained as described in ref. 13. To 
isolate the ia04 mutation, N2 worms were mutagenized with ethyl methyl sulfonate, and the 
second generation of self-progeny was screened for kif-1 deletion mutations by PCR (14). 
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The isolated deletion mutant was backcrossed to Bristol strain N2 nine times. To score 
viability in hypoxic conditions, animals were cultured on NGM plates in a sealed Plexiglas 
chamber with constant gas flow at 22°C. Compressed air and pure N2 were mixed to achieve 
the appropriate oxygen level, which was monitored by an oxygen analyzer. The transgenic C. 
elegans described here were generated by using standard protocols, and in each case, the 
coinjection marker was rol-6(suJ006) (15). 
Molecular Biology. The complementary DNAs for T01D3.2 and C15C8.2 were isolated 
from an embryonic cDNA expression library (16). The hif-1 cDNA plasmid pR8 was excised 
from the phage clone yk339c5 (from Y. Kohara, National Institute of Genetics, Shizuoka, 
Japan). The cDNA was modified to include a Kozak consensus transitional start site ( 17) by 
amplifying the hif-1 cDNA fragment by using two primers: PASBôf, 5-GCTCTAGAGCCA-
ACCATGGAAGACAATCGGAAAAGAAAC; and PASB2a, 5'-C AGTTG A A ACTTTT G A-
ATGAACCAGG. The PCR product was then cut with Xba I to generate a 150-bp fragment, 
which was subsequently cloned into the two Xba I sites of pR8 to create pR33. To generate 
the hif-1 :GFP expression construct pR19, a 9.0-kb Kpn I fragment containing the hif-1 
transcriptional start was excised from cosmid F38A6 and cloned into the Kpn I site of pSP72. 
A Pst I-Sma I fragment from the resulting plasmid was cloned into pPD95.75 (provided by 
A. Fire, Carnegie Institution of Washington). pHJ06 contains all of the hif-1 coding sequence 
fused in-frame to green fluorescent protein (GFP). pHJ06 was generated by inserting an hif-1 
cDNA fragment into pR19. To create the aha-l:gfp plasmid pHJ02. 2.8 kb of 5' regulatory 
sequence and the entire coding region of aha-1 was inserted into the pPD95.75 vector. 
Antibodies, in Situ Staining, and Immunoprecipitation. A bacterially expressed fusion 
protein containing AHA-1 (amino acids 8-57 and 353-451) and glutathione S-transferase was 
used to immunize mice and generate the 10H8 mAb. Immunostaining was performed as 
described (18). Images were captured with a Spot RT digital camera (Roche Diagnostics) on 
a Nikon E800 microscope. A commercially available GFP-specific mAb (Roche Diagnostics) 
was used to detect HIF-1:GFP on protein blots. 
HIF-1 and AHA-1 were expressed in rabbit reticulocyte lysates (Promega TNT 
system) by using expression constructs pR33 and pJ343 (19). Radiolabeled methionine was 
included in the translation reaction, and the products were assayed by SDS/PAGE. A rabbit 
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polyclonal antibody specific to AHA-1 (H.J., S. Wu, R.G., W. B. Wood, and J.A.P.-C., 
unpublished data) was used to immunoprecipitate AHA-1 and associated proteins. This 
process was performed as described in ref. 20, with an additional wash in 0.5 M LiC 1/100 
mM Tris-HCl, pH 7.4. 
Results 
Identification of hif-1. To determine whether the molecular mechanisms that regulate 
hypoxia response in C. elegans are similar to those described in mammals, we searched the 
C. elegans genome (21) for sequences encoding potential homologs of mammalian hypoxia-
inducible factor a subunits (HIF-la, HIF-2a, and HIF-3a). The proteins that dimerize to 
form the hypoxia-inducible factor complex are members of a family of transcription factors 
containing basic helix-loop-helix (bHLH) and Per-ARNT-Sim (PAS) domains (3. 22). The 
bHLH domain is required for DNA binding and dimerization (23), and the PAS domain 
mediates interactions with other proteins and regulates dimerization specificity (23, 24). We 
isolated and sequenced complementary DNAs for the five genes in the C. elegans genome 
that were predicted to contain both of these motifs (ahr-1, aha-1, F38A6.3, T01D3.2, and 
C15C8.2). F38A6.3 encodes the C. elegans gene product with the highest sequence similarity 
to the bHLH and PAS domains of mammalian HIF-la, and we named the gene hif-1. The 
predicted hif-1 gene product has 42% identity and 67% similarity to human HIF-la in the 
bHLH domain, and it has 30% identity and 55% similarity to HIF-la in the two PAS core 
domains (Fig. la). C. elegans HIF-1 is similarly related to the mammalian HLF-2a and HIF-
3a proteins within the bHLH-PAS regions. Phylogenetic analysis suggests that hif-1 
diverged from the ancestral HIFa gene before the gene duplication events that gave rise to 
mammalian HIF-la, HIF-2a, and HIF-3a. 
We designed experiments to test the hypothesis that hif-1 had biochemical and 
functional similarities with mammalian HIFa subunits. This hypothesis predicted that (z) hif-
1 mutants would be deficient in hypoxia response; (zï) the hif-1 gene product would interact 
with aha-1, the C. elegans ortholog of mammalian ARNT (19); (zzz) HIF-1 protein would be 
more highly expressed in hypoxic conditions; and (z'v) both aha-1 and hif-1 would be 
expressed in most, if not all, cells. 
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hif-1 Mediates Response to Hypoxia. To determine whether hif-1 function was required for 
adaptation to hypoxia, we mutagenized C. elegans with ethyl methane sulfonate and screened 
for deletions in the hif-1 gene. The hif-1 (ia04) mutation is a 1,231-bp deletion of the second, 
third, and fourth exons. We analyzed hif-1 complementary DNA in the mutant and 
determined that the first exon splices to the fifth exon, resulting in deletion of most of the 
bHLH and PAS domains, a shift in frame, and a premature translational stop (Fig. lb). This 
mutation likely results in complete loss of hif-1 function. 
C. elegans adapt to environmental oxygen levels below 4% by decreasing their 
metabolic rate. At 1% oxygen, their metabolic rate is decreased by half (12). As shown in 
Table 1, wild-type C. elegans embryos hatch and grow to become fertile adults in 1% 
oxygen. However, 66% of hif-1 mutants do not survive embryogenesis when cultured in 
these hypoxic conditions. The requirement for hif-1 is alleviated when oxygen levels are 
raised to 2% (Table 1), and there is no critical developmental requirement for hif-1 when the 
animals are incubated in standard laboratory conditions (21% oxygen). 
Table 1. hif-1 mutants have reduced viability in hypoxic conditions 
Wild type hif-l(ia04) 
Oxygen 
levels. % 
Embryonic 
lethality. % 
Larval 
lethality. % N 
Embryonic 
lethality. % 
Larval 
lethality. % N 
21 1.3 0.8% 475 0.2% 2% 501 
2 ND ND — 2.3% 1.6% 736 
1 3.6 2.4% 503 66.3% 9.4% 596 
ND: not determined. 
HIF-1 Binds AHA-1. The mammalian hypoxia-inducible factors consist of two protein 
subunits: HIF-la (or the related HEF-2a or HEF-3a) and ARNT (or ARNT2 or ARNT3) (2). 
To determine whether C. elegans HIF-1 forms a similar complex, we assayed its ability to 
bind AHA-1, the ortholog of mammalian ARNT (19). We expressed both gene products in 
rabbit reticulocyte lysates and immunoprecipitated the proteins with an antibody that 
specifically recognizes AHA-1. When HIF-1 is coincubated with AHA-1, both proteins are 
immunoprecipitated (Fig. 2, lane 5). Thus, HIF-1 binds AHA-1 in vitro. 
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HIF-1:GFP Protein Levels Are Increased by Hypoxia. The degradation of mammalian 
HIFa protein is inhibited when oxygen levels are low. Therefore, we predicted that the 
expression of C. elegans HIF-1 protein would increase in hypoxic conditions. To test this, we 
generated transgenic animals carrying pHJ06, a reporter gene containing 2.7 kb of hif-1 5' 
regulatory sequence and the entire hif-1 coding sequence fused to GFP (25). Transgenic 
worms were incubated in hypoxic conditions for 8 h. A fraction of the worms was then 
reoxygenated for 10 min. The expression of HIF-l:GFP was assayed by immunoblot by 
using a GFP-specific antibody. As shown in Fig. 3, HIF-1:GFP expression is increased by 
hypoxia treatment, and the protein is rapidly degraded upon reoxygenation. hif-1 mRNA is 
not substantially increased by hypoxia treatment (data not shown). The levels of AHA-1 
protein remained constant, regardless of oxygen concentration (Fig. 3). 
aha-1 and hif-1 Are Broadly Expressed. C. elegans do not have a complex circulatory 
system. Instead, they rely on diffusion for gas exchange. Therefore, individual cells must 
sense and respond to hypoxic conditions. We expected that most, if not all, cells would 
express hif-1 and aha-1. To test this hypothesis, we assayed the expression of reporter 
constructs in which hif-1 or aha-1 regulatory sequence directed the transcription of GFP. The 
hif-1 :gfp fusion gene encoded by the pHJ06 plasmid was not appropriate for this study 
because it includes the region(s) of hif-1 that mediate oxygen-dependent degradation. 
Instead, we used the pR19 plasmid, which contains 2.7 kb of hif-1 5' regulatory sequence and 
the genomic sequence encoding the first 45 aa of hif-1 fused to GFP. Transgenic animals 
carrying this reporter express GFP at high levels in every somatic cell (Fig. 4a). The aha-
l. gfp fusion gene contains 2.8 kb of aha-1 5' regulatory sequence and the complete aha-1 
coding region, aha-1 :gfp is expressed in many cell types throughout development, including 
hypodermal cells, intestinal cells, pharyngeal cells, and neurons (Fig. 4c). To further 
analyze AHA-1 expression, we generated the 10H8 mAb, which recognizes AHA-1 on 
protein blots and in situ. 10H8 recognizes AHA-1 in every cell of the C. elegans embryo 
(data not shown). Thus, aha-1 and hif-1 are both expressed in most, if not all, cells. 
Nuclear Localization of AHA-1 Depends on hif-1 Function. We used the 10H8 antibody to 
compare the subcellular localization of AHA-1 in wild-type and -defective animals. We 
reasoned that the interactions between HIF-1 and AHA-1 might be more readily detectable in 
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cells that did not express other bHLH-PAS proteins, which might dimerize with AHA-1 
and/or HIF-1. Therefore, we focused on the intestinal cells, which do not express any of the 
other C. elegans genes that include bHLH and PAS motifs (H.J., S. Wu, R.G., W. B. Wood, 
and J.A.P.-C., unpublished data). In the intestinal cells of wild-type animals, AHA-1 
localization is predominantly nuclear (Fig. 5b). In the hif-1 mutants, this expression pattern is 
disrupted. In most cases, the staining is either slightly stronger in the nucleus or diffuse 
throughout the entire intestine (Fig. 5 d and f). These data suggest that AHA-1 is not 
efficiently localized to the intestinal nuclei in the hif-1 mutant. It is also possible that AHA-1 
may be destabilized in the absence of hif-1. This requirement for hif-1 is cell type-specific, as 
AHA-1 is localized to the nuclei of some neuronal cells in the hif-1 mutant (data not shown). 
Total AHA-1 levels are equivalent in wild type and hif-1 mutant animals (Fig. 5a). 
Discussion 
These data demonstrate that C. elegans hif-1 is a functional homolog of mammalian HIFa. 
First, hif-1 mutants cannot adapt to 1% oxygen. Second, the level of a HIF-1:GFP fusion 
protein is regulated by oxygen concentration. Third, HIF-1 forms a complex with AHA-1, the 
C. elegans ortholog of ARNT (HIF-1) in vitro. The gene products also interact in vivo, as the 
nuclear localization of AHA-1 depends on hif-1 function in intestinal cells. Fourth, HIF-
1:GFP and AHA-1 are expressed in most, if not all, cells. 
Physiological Role of hif-1. Although mammalian HIF-1 has an essential role in embryonic 
development, hif-1 defective C. elegans are viable and fertile when cultured in standard 
laboratory conditions. This reflects the relatively simple physiology of C. elegans. A 
mammalian embryo relies on hypoxia-induced angiogenesis to oxygenate tissues. Hif-1'" 
mice die by E9.0 with severe vascular defects (4,5). In contrast, an adult C. elegans 
hermaphrodite has no apparent need for specialized respiratory structures or a complex 
circulatory system. Any cell in the organism is only a few cell widths from the outer surface 
of the worm or the intestinal lumen (26). 
Oxygen sensing and hif-1 function is likely to be very important in the soil 
environment inhabited naturally by C. elegans. In the laboratory, C. elegans are cultured on 
top of an agar-based medium, and the ambient oxygen concentrations are relatively high. 
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However, high concentrations of bacteria, the C. elegans food source, can deplete oxygen in 
a soil microenvironment. The nematodes must be able to sense and adapt to these hypoxic 
conditions. 
Regulation of AHA-1 Nuclear Translocation. We find that AHA-1 translocation to the 
nuclei of intestinal cells is inefficient in hif-1 mutants. This result was not predicted by the 
prevalent models for hypoxia signaling. In the mammalian cell lines commonly used to study 
hypoxia-inducible factor or aryl hydrocarbon receptor (AHR) signaling, ARNT is localized 
to the nucleus constitutively. After HIF-1 or activated AHR translocates to the nucleus, it 
forms a dimer with ARNT (2). However, in the Drosophila embryo, Drosophila ARNT 
(encoded by the tango gene) apparently remains cytoplasmic until a bHLH-PAS dimerization 
partner is expressed (27, 28). We conclude that the role of AHA-1 in the formation and 
nuclear localization of an active transcriptional complex may depend on cell type-specific 
factors, such as the expression of other bHLH-PAS proteins. We will explore this hypothesis 
by examining the expression of other bHLH-PAS genes in those cells that localize AHA-1 to 
the nucleus in the absence of hif-1. 
Importance of a Genetic Model System for the Study of Hypoxia. A thorough understanding 
of the molecular mechanisms by which cells sense and respond to hypoxia is essential to the 
treatment of many human diseases, including cancer, stroke, and cardiac failure. However, 
several critical questions remain. The oxygen sensors are undiscovered, and it will be 
important to determine how they regulate HIFa stability. Insulin signaling has also been 
shown to activate the hypoxia-inducible factor (29-31), but the roles of this interaction during 
hypoxia response, cellular differentiation, or tumor progression are not understood. Other 
signal transduction pathways may also modify hypoxia-inducible factor to modulate cellular 
response to low oxygen levels (32). 
C. elegans is an increasingly powerful model system for the dissection of signal 
transduction pathways, and further genetic analysis of hif-1 and its interacting genes will 
likely reveal mechanisms of hypoxia signaling and response that are conserved throughout 
the animal kingdom. In support of this hypothesis, a putative homolog of VHL has recently 
been identified in C. elegans (33), and the cul-2 gene encodes another evolutionary 
conserved component of the ubiquitin-proteasome proteolytic mechanism (34). 
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While this manuscript was in review, two studies were published that demonstrated 
that mammalian HIFa is targeted for VHL-mediated degradation by proline hydroxylation 
(35,36). The modified proline and an essential leucine have been identified in HIFa, and 
these residues are conserved in C. elegans HIF-1 (35). 
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Fig. 1. (a) Conserved N-terminal domains of the predicted HIF-1 protein, and the hif-I 
genomic structure. Alignment of the N-terminal amino acid sequences of human HIF-la 
(H.s. HIF-la; U22431). HIF-2a (H.s. HIF-2a; US 1983), and C. elegans HIF-1 (C.e. HIF-1: 
AF364604). Identical and similar amino acids are highlighted in black and gray, respectively, 
(b) Genomic structure of hif-1 and the hif-1 (ia.04) deletion mutant. Boxes represent exons. * 
indicate the first stop codon in the hif-1 ORF. The ia04 mutation is a 1.231-bp deletion of the 
second, third, and fourth exons. This introduces a frameshift and premature stop in the mutant 
mRNA. 
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Input IP 
+ 
1 2 3 4 5 
Fig. 2. HIF-1 binds AHA-1. HIF-1 and AHA-1 were expressed in rabbit reticulocyte lysates 
in the presence of [35S]methionine (lanes I and 2). subjected to immunoprecipitation with an 
AHA-l-specific antibody (IP; lanes 3-5). fractionated by SDS/PAGE. The antibody 
immunoprecipitates AHA-1 (lane 3) but not HIF-1 (lane 4). When AHA-1 and HIF-1 are 
coincubated. the antibody pulls down both proteins (lane 5). The molar ratio of HIF-l/AHA-1 
in lane 5 is 1:2.5. 
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21% 0.1% ReOx 
HIF-1 :GFP 
AHA-1 
ReOx 
HIF-1 :GFP 
AHA-1 
Fig. 3. HIF-l:GFP protein levels are increased by hypoxia. The transgenic C. elegans strain 
pHJ06 Ex6. which expresses the complete HIF-1 protein fused to GFP. was harvested before 
(21% 02) and after incubation in 0.1% oxygen (Upper) or 1% oxygen (Lower) for 8 h. In 
each experiment, a fraction of the hypoxia treated worms were reoxygenated for 10 min 
(ReOx). Worms were lysed by boiling in loading buffer, and equal amounts of total protein 
were loaded in each lane. The expression of HIF-1 :GFP and AHA-1 was assayed by probing 
the immunoblot with a GFP-specific antibody and the AHA-1-specific mAb 10H8. 
Fig. 4. hif-1 and aha-1 promoters direct expression of GFP reporter genes in most cell types. 
Fluorescent images and Nomarski images of a C. elegans first-stage larvae expressing hif-
l:gfp (a and b) and aha-1 :gfp (c and d). 
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IH 
•• 
Fig. 5. Subcellular localization of AHA-1 is disrupted in the hif-I(ia04) mutant, (a) Equal 
amounts of total protein from wild-type (N2) or hif-l(ia04) were size-fractionated by 
SDS/PAGE. blotted, and probed with the AHA-1-specific antibody 10H8. (b. d. and f) 
Immunostaining of intestinal cells with 10H8 in wild-type (N2) (b) or hif-I mutant adults (d 
and f). (c. e. and g) The 4'.6-diamidino-2-phenylindole staining of the cells that are shown in 
b. d. and f, respectively. The arrowheads label the positions of intestinal cell nuclei. 
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CHAPTER 3 
An essential function for C. elegans bHLH-PAS proteins: Evidence that 
aha-1 and cky-1 have a role in pharyngeal function 
A paper to be submitted to Developmental Biology 
Huaqi Jiang1, Shu Wu:, Colleen Gary3, William B. Wood, and Jo Anne Powell-Coffman4 
ABSTRACT 
The family of basic-helix-loop-helix-PAS (bHLH-PAS) transcription factors mediate 
diverse cellular processes, including several important cell fate decisions during development 
and adaptations to environmental signals. Molecular and biochemical data indicate that C. 
elegans aha-1 encodes the ortholog of the mammalian aryl hydrocarbon receptor nuclear 
trans locator (ARNT). Previous studies have shown that AHA-1 is expressed broadly, and it 
can form complexes with AHR or HIF-1. To better understand the role of aha-1 in ahr-1 and 
hif-1 signaling and to reveal other functions of bHLH-PAS proteins, we isolated deletion 
mutations that abolish aha-1 function, aha-1 deletion mutants arrest as larvae and are 
defective in feeding. The larval arrest phenotype of aha-1 mutants is much more severe than 
the ahr-1, hif-1 double mutants (which are viable), suggesting that aha-1 has additional 
functions. We analyzed the expression patterns of the two remaining bHLH-PAS genes, 
T01D3.2 and cky-1. A T01D3.2:GFP reporter is expressed in two intemeurons. cky-1 may 
represent a new bHLH-PAS gene subfamily, and a CKY-1 :GFP reporter is expressed mainly 
in the pharynx, which is the feeding organ of the worm. These data suggest that AHA-1 and 
CKY-1 might interact and function in the pharynx. Several lines of evidence support this 
model: AHA-1 and CKY-1 form a DNA-binding complex in vitro. AHA-1 is nuclear 
localized in the subset of pharyngeal cells that also express CKY-1 GFP. A cky-1 :aha-l 
fusion, in which a cky-1 upstream sequence was placed upstream of the aha-1 coding 
1 Primary researcher and author 
2 S. W. is a graduate student in the laboratory who performed the gel-shift assay for AHA-1 homodimer. 
' C. C. is an undergraduate assistant who generated the 6 His-AHA-1 fusion protein. 
* J.A.P-C. is the corresponding author, who is a postdoctoral fellow in W.B.W.'s laboratory from 1994-1997, 
where this study was initiated. 
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sequence, was able to rescue the aha-1 mutant phenotype. We propose that aha-1 has an 
essential function in the C. elegans pharynx. 
INTRODUCTION 
During the development of multicellular organisms, individual cells must recognize 
and respond to developmental and environmental signals. Many important cellular responses, 
such as cell differentiation, proliferation, apoptosis and migration, require specific changes in 
gene expression. To understand these processes, we must first identify the transcriptional 
factors involved and determine how they are regulated. The family of transcription factors 
containing basic, helix-loop-helix, and Per-ARNT-Sim (PAS) domains (bHLH-PAS proteins) 
regulate several very important developmental processes and mediate adaptation to certain 
environmental changes, including circadian rhythm regulation, neuronal differentiation and 
adaptation to hypoxia (reviewed in Crews and Fan, 1999 and Gu et al., 2000). 
One of the most studied bHLH-PAS protein complexes is mammalian AHR and its 
nuclear trans locator ARNT. AHR is a ligand-activated receptor, and it mediates the toxic 
effects of certain pollutants, including dioxin and polycyclic aromatic hydrocarbons (PAHs), 
such as benzo[a]pyrene (Bock, 1994). Mammalian HIF-la also interacts with ARNT. The 
heterodimer is called hypoxia-inducible factor-1 (HIF-1), and it regulates transcriptional 
responses to hypoxia (Wang et al., 1995). Although AHR, HIF-la and most of the other 
bHLH-PAS proteins are each dedicated to a specific developmental or cellular function, 
proteins in the ARNT subfamily are included in every DNA-binding bHLH-PAS protein 
complexes identified thus far. This range of protein interactions predicts that ARNT proteins 
should be required for multiple developmental functions, and this has been confirmed by 
genetic analyses. For example, ARNT-deficient mice have defects in embryonic angiogenesis 
that are similar to those exhibited by HIF-la null mice (Iyer et al., 1998; Kozak et al., 1997; 
Maltepe et al., 1997; Ryan et al., 1998). Mice lacking ARNT2 or SIM1 have similar defects 
in neuronal differentiation in the hypothalamus (Hosoya et al., 2001; Keith et al., 2001; 
Michaud et al., 2000; Michaud et al., 1998). Both MOP3/ARNT3 and CLOCK null mice are 
arrhythmic (Antoch et al., 1997; Bunger et al., 2000; King et al., 1997). Drosophila ARNT is 
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encoded by the Tango (tgo) gene. The tgo mutant phenotypes also confirmed that it has 
multiple functions in Drosophila development. These including CNS midline specification 
(Tgo/Sim), tracheal pit formation (Tgo/Trh) and development of distal antenna, distal leg and 
bristles (Tgo/Ss)(Emmons et al., 1999; Sonnenfeld et al., 1997). 
Biochemical analyses have shown that ARNT homodimers bind a class B E-box 
enhancer that contains two adjacent ARNT half sites (Antonsson et al., 1995; Sogawa et al.. 
1995; Swanson et al., 1995). Further, this enhancer can direct reporter gene expression in 
mammalian tissue culture cells in an ARNT-dependent manner (Antonsson et al., 1995; 
Sogawa et al., 1995). However, the putative transcriptional targets of ARNT homodimers 
have not been identified. The role of ARNT homodimers is also unclear in genetic model 
systems. Efficient nuclear localization of Drosophila Tgo is dependent upon co-expression of 
a heterodimerization partner (Ward et al., 1998). Similarly, the ARNT homolog in C. 
elegans, AHA-1, is not efficiently nuclear localized in intestinal cells in the absence of its 
dimerization partner HIF-1 (HIFa homolog) (Jiang et al., 2001). This data suggests that if 
homodimers form in vivo, they are not translocated to or stabilized in the nucleus as 
efficiently as bHLH-PAS heterodimeric complexes. 
Other studies suggest that ARNT function may be regulated by other cell type 
specific signal transduction pathways. Mammalian ARNT is phosphorylated at multiple sites 
(Levine and Perdew, 2001). Dephophorylation of ARNT reduces its activity to form 
heterodimers with AHR in vitro (Berghard et al., 1993). Protein Kinase C (PKC)-dependent 
phosphorylation events have been demonstrated to enhance AHR signaling and ARNT 
homodimer activity (Chen and Tukey, 1996; Long et al., 1999). However, it is not clear 
whether PKC directly phosphorylates ARNT and/or AHR. 
C. elegans is a simple genetic system, and it is ideal to study the complex function 
and regulation of bHLH-PAS proteins. The C. elegans genome encodes 5 bHLH-PAS genes 
(Jiang et al., 2001; Ledent and Vervoort, 2001). These include aha-1, ahr-1 and hif-l, which 
are homologs of ARNT, AHR and HIFa respectively (Jiang et al., 2001; Powell-Coffman et 
al., 1998). C. elegans AHR-1, AHA-1 and HIF-1 have been shown to be biochemically 
similar to their mammalian cognates. C. elegans hif-l mutants fail to adapt to hypoxia (Jiang 
et al., 2001). To clarify the role of aha-1 in ahr-1 and hif-l signaling in C. elegans and to 
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identify other potential functions of bHLH-PAS proteins, we isolated deletion mutations in 
aha-1. We report that aha-1 has an essential function during larval development, in addition 
to its roles in AHR and hypoxia signaling. The two remaining bHLH-PAS genes, cky-1 and 
T01D3.2 are expressed in the pharynx and a pair of intemeurons, respectively. We present 
evidence that AHA-1 interacts with CKY-1. Further, expression of aha-1 from the cky-1 
upstream fragment is sufficient to rescue aha-1 mutants to viability. 
MATERIALS AND METHODS 
Worm Strains, Transformation and RNAi 
The following C. elegans strains were used in this study: wild type, Bristol N2; 
CB1091, une-13(e 1091) I; MTl 196, Iin-U(n566) I; DR466, him-5(el490) V, mut-2(r459) I. 
ZG3, aha-1 (ct383) mut-2(r459) I; ZG5 aha-l(ia01 )/lin-l l(n566) I; ZG6 aha-l(ia02)Ain-
U(n566) I. 
Worm cultures were grown under standard conditions (Brenner, 1974). DNA 
constructs were transformed into worms by co-microinjection with the roller marker pRF4, 
rol-6(sul006) (Mello etal., 1991). Multiple lines for each transformation were generated and 
analyzed. 
Isolation of aha-1 Mutations 
The ZG3 strain contains both the aha-l(ct383) Tel insertion and the mut-2(r459) 
allele, which allows transposon mobility. PCR screening protocols (Plasterk, 1995) were 
used to identify the ct383 allele in a transposon insertion library, which was constructed in 
the laboratory of J. Priess (U. of Washington). A PCR-based sib selection protocol was used 
to identify the two aha-1 deletion alleles, iaOl and ia02, among ZG3 progeny (Plasterk, 
1995). The isolated deletion alleles were out-crossed with wild type up to 6 times. The 
closely linked marker une-13(el091) was crossed on and off both alleles to eliminate other 
potential mutations and to remove the mut-2(r459) prior to phenotypic analysis. Both alleles 
were balanced with Iin-U(n566). 
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Phenotypic Analysis of aha-1 Mutants 
The larval lethality phenotype of aha-1 mutants was assayed using ZG5 aha-
l(iaOl)Ain-l l(n566) and ZG6 aha-l(ia02)Ain-ll(n566). The number of arrested larvae were 
counted 2 days after hatching when the smaller arrested mutant larvae were readily 
distinguishable from their wild type siblings. 
The feeding efficiency assay was modified from the methods originally described 
(Avery and Horvitz, 1987) (Avery and Horvitz, 1990) as follows. For wild type N2, 
synchronized larvae were assayed at the first and second larval stages (most of the aha-1 
mutants arrest at these stages). The progeny of aha-l(ia01)Ain-Il(n566) were assayed 24, 36 
and 48 hours after hatching. 24 hours after hatching, aha-1 mutants are readily 
distinguishable from their bigger wild type siblings. After incubating in a 1:100 mixture of 
ink (Pelikan, Fount India) and OP50 bacterial suspension for 20 minutes, worms were 
quickly paralyzed by adding sodium azide to a final concentration of 0.05%. The presence of 
ink particles in the gut lumen was checked by microscopy. The experiments were repeated 3 
times, each time about 30 animals were checked for the presence of ink particles in the gut 
lumen. To observe the "stuffed" phenotype, 2 day-old aha-1 mutants were placed on NGM 
plates spotted with OP50 mixed with 1:100 dilution of ink. After 24 hours, animals were 
photographed using a Spot RT digital camera (Roche Diagnosis) on a Nikon E800 
microscope. 
cky-1 and T01D3.2 GFP Reporter Constructs 
To create the cky-1 GFP reporter construct pR15, a 4.3 kb Sal I/Bgl H fragment from 
cosmid C15C8, containing 2.5 kb sequences upstream of the cky-1 transcription start and part 
of the genomic coding region (codons 1-102), was cloned into the Sal I/BamH I sites of 
pPD95.67. 
The T01D3.2 GFP reporter construct pR14 was generated in two steps. First, a 7 kb 
Kpn I fragment from cosmid T01D3 was subcloned into the Kpn I site of pBluescript SK(H) 
to generate pRIO. Then a 3.8 kb S ma I/Nhe I fragment from pRIO, which contains 3.6 kb 5' 
sequences from the T01D3.2 translational start and part of the genomic coding regions 
(codons 1-31), was cloned into the Hind in/Xba I (Hind m end was blunted using DNA 
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polymerase I Klenow) of pPD95.75. The GFP reporter constructs were created by A. Fire 
and colleagues (Carnegie Institute of Washington). 
aha-1 Rescue Constructs 
Two aha-1 rescue constructs were used in this study, (i) pHJ28 is a subclone of 
C25A1 (32,739 bp - end), and it contains the entire aha-1 genomic region, including 2.8 kb 
sequences 5' to ATG, the entire coding region and 2.1 kb sequences downstream of the poly 
A addition site. (ii). pHJ32 was designed to ectopically express AHA-1 in a subset of 
pharyngeal cells. A cky-1 genomic fragment containing the same 5' sequences used in pR15 
(Sal I/Sac I fragment from pR15) was fused to an aha-1 genomic fragment (BamH I/Bgl H 
fragment from pHJ28). To complete the aha-1 coding sequence, an oligonucleotide adapter 
containing the first 6 codons of aha-1 was added (Figure 4A). 
DNA Binding Assay and Immunoprecipitation 
The cky-1 cDNA clone pR7 was isolated from an embryonic cDNA library (Okkema 
and Fire, 1994). In pR7\ the sequence proceeding the translational start site was modified to 
create the Kozak consensus site (Kozak, 1987). CKY-1 and AHA-1 were expressed in rabbit 
reticulocyte lysates (Promega TNT system) using expression vectors pR7' and pJ343 
(Powell-Coffman et al., 1998). 
Immunoprecipitation assays were performed as described previously (Jiang et al., 
2001). Briefly, proteins were translated in vitro and labeled with [35S-]Methionine. The 
AHA-1 specific monoclonal antibody 10H8 (Jiang et al., 2001) was used to 
immunoprecipitate AHA-1 and associated proteins. The precipitates were assayed by SDS-
PAGE. 
Gel mobility shift assays were performed as described previously (Powell-Coffman et 
al., 1998). For the CKY-l/AHA-1 DNA binding assay, the XRE probe was 5'-
TCGAGGGGCATTGCGTGACACC, annealed to 5 -TCGAGGTGTCACGCAATGCCCC. 
The XREmut competitor was 5'-TCGAGGGGCATTGACTGACACC. annealed to 5'-
TCGAGGTGTCAGTCAATGCCCC (the binding site is in bold, and the mutations are 
underlined). For the AHA-1 homodimer DNA binding assay, the AHAwt probe was 5'-
TCGACAAAGGTCACGTGATTGTGG, annealed to 5'-
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TCGACCACAATCACGTGACCTTTG. The AHAmutl competitor was 5'-
TCGACAAAGGTCACATGATTGTGG, annealed to 5'-
TCGACCACAATCAIGTGACCTTTG. Another competitor, AHA-lmut2, was 5'-
TCGACAAAGGTCAIATGATTGTGG, annealed to 5'-
TCGACCACAATCATATGACCTTTG. The XRE and AHAwt probes were radioactively 
labeled using DNA polymerase I Klenow and [a-32P]dCTP. For supershift assays, l|il of 
rabbit anti-AHA-1 polyclonal antibody or 10H8 was added to the reaction mix. 4E10 is a 
negative control monoclonal antibody. The AHA-1-specific polyclonal antibody was 
generated by innoculating rabbits with a fusion protein, in which 6 histidines were fused to 
amino acids 6-451 of AHA-1. The antibody was further purified from the sera using the 
Promega Tetralink™ system by using an AHA-1 fusion protein containing a biotin tag. This 
fusion protein was generated using Promega Pinpoint™ system, in which the same AHA-1 
coding region was included. The experiments were performed as recommended by the 
manufacturer. 
RESULTS 
aha-1 is Essential 
To analyze the function of C. elegans aha-1, we isolated deletion mutations in aha-1 
using a transposon-mediated mutagenesis protocol (Plasterk, 1995). We used PCR-based 
techniques to screen a library of transposon insertions, and isolated aha-l(ct383), which 
contains a Tel insertion in the 6th intron (cosmid C25A1 35,345 bp. Figure IB), aha-
l(et383) homozygous animals are viable and fertile. Prior studies have shown that Tel 
insertions in introns do not necessarily impair function (Rushforth et al., 1993). We screened 
for aha-1 deletion alleles that were generated from imprecise excision of the transposon. We 
isolated two aha-I deletion alleles, iaOl and ia02. aha-l(iaOl) contains a 2,447 bp deletion 
(cosmid C25A1,34,680-37.127 bp), which removes all the coding sequences between exon 2 
and the poly A addition site (Figure IC). No aha-1 transcripts were detected in aha-l(iaOl) 
mutants (RT-PCR, data not shown). aha-l(ia02) contains a 1,408 bp deletion (cosmid 
C25A1 35,345-36,753 bp) of part of exon 3 and exons 4-6. A 281 bp Tel fragment remains. 
This results in a frame shift and a premature stop codon immediately downstream of the 
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deletion (Figure ID; the structure of the mutant transcript was confirmed by RT-PCR). These 
molecular analyses suggest that iaOl and ia02 are both strong loss-of-function alleles and are 
likely nulls. The arrest phenotypes for iaOl and ia02 are very similar (see below), and except 
where noted, the iaOl allele was used for the studies described here. 
Animals that are homozygous for either aha-1 deletion mutation arrest development 
as larvae, and this defect is completely penetrant (iaOl, n=814; ia02, n=768). 92.5% (n=133) 
of iaOl mutants arrest at the first or second larval stage, and the remainder arrest 
development before adulthood. Some of the arrested larvae survive up to 2 weeks. The 
arrested larvae have pale intestines. This phenotype is characteristic of starved animals, and it 
suggested that aha-1 mutants might have pharyngeal or intestinal defects. 
The pharynx is a rhythmically contracting neuromuscular organ at the anterior end of 
the animal that pumps the bacterial food source into the intestine and initiates digestion. To 
assay pharyngeal function in aha-1 mutants, we mixed ink with the bacterial food source. 
After feeding for 20 minutes, ink particles are visible in the intestine of >97% of first or 
second stage wild type larvae (Figure 2A&C). In contrast, 24 hours after hatching, less than 
50% of the aha-1 mutants contain ink particles in the intestines (Figure 2C). This phenotype 
becomes more severe after longer periods of arrest (Figure 2C). In addition, 35% (n=94) of 
the terminally arrested larvae had a "stuffed" pharynx phenotype 3-4 days after hatching. In 
these animals, bacteria are lodged in the pharyngeal lumen (Figure 2B). The severity of the 
aha-1 mutant phenotype demonstrates that aha-1 has essential developmental functions that 
are independent of ahr-1 or hif-l function, ahr-1, hif-l single or double mutants are viable 
(Jiang et al., 2001; unpublished data). 
The larval arrest phenotype of aha-l(iaOl) was fully rescued by pHJ28, a subclone of 
C25A1 that contains the aha-1 genomic region (see Materials and Methods for details). 
Expression of C. elegans bHLH-PAS Genes cky-1 and T01D3.2 
To better understand the essential functions of aha-1, we examined the expression 
pattern of potential bHLH-PAS dimerization partners. The C. elegans genome encodes 5 
members of this family, ahr-1, hif-l, and aha-1 have been described in previous studies 
(Jiang et al., 2001; Powell-Coffman et al., 1998). ahr-1 is expressed primarily in neurons 
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(Qin and Powell-Coffman, unpublished data), hif-l is ubiquitously expressed and is required 
for adaptation for hypoxia (Jiang et al., 2001). We generated GFP reporter constructs to 
examine the expression patterns of the two remaining bHLH-PAS genes, T01D3.2 and 
C15C8.21 cky-1. 
The T01D3.2:GFP reporter pR14 contains 3.6 kb upstream sequence and codons 1-31 
of T01D3.2 fused to GFP. The positions of the neuronal cell bodies and axon tracts are 
shown in Figures 3C&D. In mid-embryogenesis, GFP expression is observed in 4 cells (2 
each side) in the head. At the 1.5-fold embryonic stage, two GFP-expressing cells (one on 
each side) begin neuronal differentiation. The other two undergo apoptosis (Figure 3A&B). 
Postembryonic GFP expression is only detected in two intemeurons. We conclude that the 
cells expressing T01D3.2:GFP are the AVH intemeurons (Sulston et al., 1983; White et al., 
1986). No essential function has been described for these neurons. 
The CKY-l:GFP reporter pR15 contains 2.5 kb upstream sequence and codons 1-102 
of CKY-1. GFP expression was first detected in the pharyngeal primordium at the two-fold 
stage of embryogenesis (Figures 4B&C), and pharyngeal expression was maintained during 
all later developmental stages. A mature pharynx consists of 80 nuclei and 5 different cell 
types (Albertson and Thomson, 1976). CKY-1 :GFP was expressed in all pharyngeal muscle 
cells, g2 gland cells, epithelial cells, marginal cells and pharyngeal-intestinal valve cells 
(Figure 5, D-F). CKY-1 :GFP expression was not detectable in any of the pharyngeal neurons 
or in the g I gland cells. 5-10 cells immediately outside of pharynx also expressed CKY-
1:GFP (Figures 4B&D, indicated by asterisks). 
AHA-1 is Nuclear Enriched in a Subset of Pharyngeal Cells 
Nuclear localization of AHA-1 may require co-expression of a dimerization partner 
(Jiang et al., 2001). To determine whether expression of CKY-lzGFP correlated with nuclear 
localization of AHA-1, we stained wild type animals with the AHA-1 specific monoclonal 
antibody 10H8. As previously reported, AHA-1 is expressed in most, if not all, somatic cells 
(Jiang et al., 2001). As shown in Figures 5A&B, AHA-1 is also detectable in oocyte nuclei. 
In the larval pharynx, AHA-1 is nuclear enriched in the pharyngeal muscle cells, epithelial 
cells, structural marginal cells and pharyngeal intestinal valve cells (Figures 5C&D). 
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However, AHA-1 nuclear enrichment is not observed in any of the 20 pharyngeal neurons. 
This expression pattern suggests that AHA-1 has a transcriptional function that is specific to 
a subset of pharyngeal cells. Further, it suggests that a dimerization partner might be co-
expressed in these cells. 
CKY-1 Forms a Heterodimer with AHA-1 in vitro 
Nuclear localization of AHA-1 in the pharyngeal cells that express CKY-1:GFP 
suggests that AHA-1 and CKY-1 may interact. We tested this hypothesis by 
coimmunoprecipitation experiments. We expressed both gene products in rabbit reticulocyte 
lysates and immunoprecipitated the proteins with the AHA-1 specific monoclonal antibody 
10H8. As shown in Figure 6B, 10H8 is able to precipitate AHA-1, but not CKY-1. When 
CKY-1 is coincubated with AHA-1, both proteins are immunoprecipitated (Figure 6B, lane 
5). 
We used the TBLASTN algorithm (Altschul et al., 1990) to search Genebank for 
potential homologs of cky-1. We identified 3 potential mammalian cky-1 genes: a predicted 
human Open reading frame (ORF), XM_100570 and two murine expressed sequence tags 
(EST), BB623011 and BB594112, which were originally isolated from cDNA libraries 
prepared from brain tissues. The alignment of the bHLH domains is shown in Figure 6A. The 
basic and helix-loop-helix domain of CKY-1 shares 58% identity and 72% similarity with 
this potential human homolog. 
To determine whether CKY-1 and AHA-1 could form a DNA-binding complex, we 
performed electrophoretic mobility shift assays (EMS A). The bHLH domains of CKY-1 and 
its homologs are most similar with that of the AHR family (Ledent and Vervoort, 2001) 
(Figure 6A), and AHR-1 and AHA-1 interact to bind the xenobiotic response element (XRE, 
sequence 5' -TGCGTG). When AHA-1 and CKY-1 are coincubated, they bind the XRE 
probe and decrease its mobility (Figure 6C, lane 4). The binding is sequence specific: the 
labeled probe can be displaced by a 200-fold excess of unlabeled XRE (Figure 6C, lane 6) 
but not by an unlabeled competitor containing a mutant XRE (XREmut2,5' -TGCGTG 
mutated to 5' -TGACTG) (Figure 6C, lane 7). Addition of the AHA-1 specific monoclonal 
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antibody generated a supershift (SS). (Figure 6C, lane 8). The formation of only one 
supershift band suggests that only one AHA-1 molecule was present in the complex. 
To determine whether AHA-1 could form a homodimeric DNA binding complex, we 
performed a similar EMS A assay using in vitro expressed AHA-1. As shown in Figure 6D, 
AHA-1 was able to bind to a probe containing a class B E-box (5-CACGTG). The addition 
of 10H8 generates two supershift bands, which indicates that the complex contains two 
AHA-1 molecules. The negative control monoclonal does not cause the complex to decrease 
mobility. 
cky-l:aha-I is able to Rescue aha-l(iaOl) Mutants 
The genetic and biochemical data presented so far support two non-exclusive models: 
AHA-1 may function as a dimer with CKY-1 in the pharynx. Alternatively, AHA-1 
homodimers may have an essential function in the pharynx or in other tissues. If formation of 
an AHA-l/CKY-1 heterodimer is essential for pharyngeal function, then cky-1 loss-of-
function mutations should cause lethality. We attempted to decrease cky-1 function via 
double-stranded RNA-mediated interference (RNAi), and progeny of the treated animals 
were viable with no obvious defects. However, this negative result may not be informative 
since some genes and tissues are known to resistant to RNAi in C. elegans (Tavemarakis et 
al., 2000; Timmons et al., 2001). In general, RNAi experiments are more likely to impair 
gene function for C. elegans genes with embryonic functions than those with postembryonic 
phenotypes (Maine, 2001). Indeed, worms treated with aha-1 dsRNA are also viable (Fraser 
et al., 2000). 
As a second approach, we generated animals that were mosaic for aha-1 function. To 
create these animals, we generated a chimeric construct, pHJ32 (Figure 4A), in which a cky-1 
upstream fragment directs the expression of the aha-1 transcript. Extrachromosomal arrays of 
this construct were able to fully rescue the larval arrest phenotype of aha-1 deletion mutants. 
To verify the AHA-1 expression pattern in these animals, the rescued animals were stained 
with the AHA-1 specific antibody 10H8, and the detectable staining was mostly restricted to 
the pharyngeal tissue (Figure 4G) and two tail neurons (a pair of PHA or PHB phasmid 
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neurons, data not show). Thus, AHA-1 is required in a subset of cells which is defined by 
CKY-1 :GFP expression. 
DISCUSSION 
C. elegans CKY-1 Form a Heterodimer with AHA-1 in vitro 
In addition to aha-1, the C. elegans genome encodes 4 other bHLH-PAS genes (Jiang 
et al., 2001; Ledent and Vervoort, 2001). In prior studies, we have shown that AHR-1 and 
HIF-1 can interact with AHA-1 in vitro (Jiang et al., 2001; Powell-Coffman et al., 1998). 
Since the larval arrest phenotype of aha-1 mutants is much more severe than that of hif-l, 
ahr-1 double mutants (the hif-l, ahr-1 double mutants are viable (unpublished data)) and 
known DNA-binding bHLH-PAS complexes all contain members of the ARNT subfamily, 
we examined other C. elegans bHLH-PAS proteins for potential dimerization partners of 
aha-1. In vitro immunoprecipitation and gel-shift assays demonstrate that CKY-1 forms 
DNA-binding heterodimers with AHA-1. In vitro expressed CKY-1 is able to co-
immunoprecipitate with AHA-1 (Figure 6B, lane 5) and CKY-l/AHA-l heterodimers bind to 
DNA probe containing the xenobiotic response element (XRE) (Figure 6C). The attempts to 
express the only other C. elegans bHLH-PAS protein, T01D3.2, were unsuccessful, and 
whether it interacts with AHA-1 is unclear. 
We further identified several mammalian homologs of cky-1 in sequence databases. 
The two murine EST (expressed sequence tag) homologs were originally isolated from 
cDNA libraries prepared from brain tissues. The predicted protein sequences of these genes 
contain a bHLH domain that is highly homologous to CKY-1 (Figure 6A). Given the strong 
conservation of AHA-1 function to its mammalian ortholog ARNT (Jiang et al., 2001; 
Powell-Coffman et al., 1998), we predict that the mammalian CKY-1 proteins form 
heterodimers with ARNT to execute their functions. CKY-1 may represent a new bHLH-
PAS protein family that is able to dimerize with ARNT. 
Evidences for an Essential Function of aha-1 in the Pharynx 
Animals homozygous for either aha-1 deletion alleles arrest at larval stages. 
Phenotypic analyses of the aha-1 mutant animals revealed a possible function in the pharynx. 
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The aha-1 mutant animals appear starved, and 35% of the terminally arrested mutants have a 
"stuffed" pharynx phenotype (Figure 2B). The C. elegans pharynx is a feeding organ that 
grinds the bacterial food source, transfers the food into the intestine and initiates digestion. 
Consistent with the possible pharyngeal function for aha-1, ink-feeding assays reveal that 
aha-1 mutants feed poorly (Figure 2C). Furthermore, expression of aha-1 from the cky-1 
upstream fragment (pHJ32, Figure 4A) is sufficient to rescue the aha-1 larval arrest 
phenotype. 10H8 immunostaining of the rescued animals revealed that AHA-1 is mainly 
detected in the pharynx (Figure 4G) and a pair of phasmid neurons (data not shown). Thus 
we propose that aha-1 has an essential function in the pharynx and the aha-1 larval arrest 
phenotype most likely resulted from the feeding defects. However, a yet uncharacterized 
pharynx-related aha-1 function may also be essential for larval development. 
The completely penetrant larval arrest phenotype of aha-1 mutants is striking. Most 
of the previously described mutations that impair pharyngeal function are viable. Many genes 
that regulate pharyngeal function have been identified in genetic screens for mutations that 
impair feeding but are not lethal, including a number of eat (eating-defective) and phm 
(pharyngeal muscle defective) mutations (Avery, 1993). The aha-1 mutants arrest at larval 
stages, so it is likely to be missed in that screen. After examining the genetic map of the 
mutations isolated in that screen, we conclude that aha-I is indeed not included. Other 
feeding defective mutations have also been identified, such as eat-20 (Shibata et al., 2000) 
and ceh-22 (Okkema and Fire, 1994). Mutant animals for them are not lethal (The ceh-22 
mutants are partially lethal, the homozygous ceh-22 mutants can be maintained as a very 
weak strain) (Okkema and Fire, 1994). 
Complete inability to feed does result in lethality, as evidenced by mutations in pha-
1, pha-2 and pha-4 (Avery, 1993; Granato et al., 1994; Mango et al., 1994). In pha-4 
mutants, the pharynx primordium is not formed (Mango et al., 1994). In pha-1 mutants, the 
pharynx primordium form but they fail to undergo terminal differentiation (Granato et al., 
1994). Both pha-1 and pha-4 mutants are embryonic lethal. In pha-3 mutants, the pharynxes 
are misshapen, and most of the mutants arrest as the first stage larvae (Avery, 1993). In 
contrast, the pharynxes of aha-1 larvae do not have major structural defects when observed 
by microscopy. MYO-2 immunostaining using monoclonal antibody 9.2.1 (Epstein et al., 
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1982) indicates that pharyngeal myosin expression and structure are normal in the aha-1 
mutant animals (data not shown). We also stained the mutant animals with monoclonal 
antibody MH27, which recognizes an adherens junction protein present around hypodermal 
cells in the pharynx (Francis and Waterston, 1991; Labouesse, 1997), and the pharyngeal 
expression pattern is comparable to that of wild type N2 (data not shown). We conclude that 
aha-1 mutants do not have dramatic structural defects in the pharynx. 
C. elegans feeding is accomplished by two separately controlled pharynx muscle 
motions, isthmus peristalsis and pumping. Isthmus peristalsis transfer the bacterial food 
source from the anterior corpus to the terminal bulb through isthmus. When pharyngeal 
neuron M4 is laser ablated, isthmus peristalsis is defective and the bacteria are lodged in the 
anterior lumen, resulting in a "stuffed" phenotype (Avery and Horvitz, 1987). Since the 
bacterial can not reach the terminal bulb and intestine, the larvae arrest. The terminally 
arrested aha-1 mutants also have a "stuffed" pharynx phenotype (Figure 2B). However, in 
most of the cases, bacteria are lodged in the entire pharynx. Furthermore, the fusion construct 
cky-1 :aha-I is not expressed in the pharyngeal neurons (data not shown), yet it still rescued 
the aha-1 larval lethal phenotype. aha-1 is unlikely involved in M4-regulated isthmus 
peristalsis. 
The C. elegans kel-1 encodes the homolog of Drosophila Kelch (Ohmachi et al., 
1999). The kel-1 mutants are feeding-defective and arrest as early larvae. But the pharynx 
structure of the kel-1 mutants is normal. Overall, aha-1 and kel-1 mutants have similar 
phenotypes. However, KEL-1 is expressed in the pharyngeal gl gland cells and is required 
for feeding in these cells (Ohmachi et al., 1999). It is unlikely that the larval arrest of aha-1 
mutants are caused by gl cell defects since CKY-1:AHA-1 is not expressed in gl gland cells 
(data not shown), yet the fusion is still able to efficiently rescue the aha-1 mutant 
phenotype. 
C. elegans pharyngeal development is organized by the fork head transcription factor 
PHA-4 (Homer et al., 1998; Kalb et al., 1998). Besides its role in early pharynx primordium 
development, pha-4 function is also required for viability after the pharynx is formed 
(Gaudet and Mango, 2002; Mango et al., 1994). When pha-4 temperature sensitive mutants 
(pha-4(ts)) were shifted to the restrictive temperature at mid-embryogenesis, they hatched 
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and arrested as first stage larvae, with a "stuffed" pharynx phenotype similar with that 
observed in the terminally arrested aha-1 mutants (Gaudet and Mango, 2002) (Figure 2B). 
This data suggests that both PHA-4 and AHA-1 have required functions in the pharynx in 
late embryogenesis and/or larval development. PHA-4 and AHA-1 may have similar 
transcriptional targets, or bHLH-PAS proteins may regulate a subset of the genes that are 
ultimately controlled by PHA-4. PHA-4 has been demonstrated to directly mediate most or 
all pharyngeal genes expression by binding to the TRTTKRY element in the promoter of 
these genes (Gaudet and Mango, 2002). Analysis of cky-1 upstream sequence identified 5 
potential PHA-4 binding sites within 1 kb upstream of ATG, suggesting that PHA-4 may 
regulate cky-1 expression directly. 
Two non-exclusive models can be used to explain the AHA-1 function in the 
pharynx: AHA-l/CKY-1 heterodimer may have an essential pharyngeal function. 
Alternatively, AHA-1 homodimers may have a critical role in the pharynx. If the 
heterodimers are the only bHLH-PAS gene function required in the pharynx, we predict that 
cky-1 mutants will have similar defects as aha-1 mutants, which is larval arrest. Treatment of 
wild type animals with cky-1 dsRNA did not result in a mutant phenotype (data not shown). 
Interestingly, feeding wild type animal with aha-1 dsRNA also did not result in larval lethal 
phenotype (Fraser et al., 2000). Thus, these negative results may not be informative. The 
resolution of this issue will require mutational analysis of cky-1. 
However, expression of aha-1 in a subset of pharyngeal cells using a cky-1 :aha-l 
fusion construct rescues the aha-1 larval arrest phenotype, which provides strong support for 
the heterodimer model. In addition, analysis of AHA-1 immunostaining revealed that AHA-1 
is nuclear localized in the subset of pharyngeal cells that also express CKY-1 :GFP, but not in 
the pharyngeal neurons which do not express CKY-1 :GFP (data not shown). Like Drosophila 
Tgo, AHA-1 lacks the N-terminal nuclear localization signal (NLS) of mammalian ARNT, 
its efficient nuclear localization in intestinal cells requires the presence of its dimerization 
partner (Jiang et al., 2001). That suggests that AHA-1 and CKY-1 may interact in those 
pharyngeal cells. 
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Maternally Contributed AHA-1 and AHA-1 Homodimer 
AHA-1 in situ immunostaining reveals that AHA-1 is detected in the developing 
oocyte nuclei, suggesting that AHA-1 is maternally contributed. However maternally 
contributed AHA-1 is unlikely have an essential function in C. elegans development. 10H8 
immunostaining of the cky-1 :aha-l rescued animals demonstrated that the CKY-1: AHA-1 is 
not expressed in the germline or intestine (some of the maternally contributed proteins are 
expressed in the intestine and subsequently transferred into oocyte) (data not shown). AHA-1 
expression is not detected until 2-fold embryonic stage. Yet zygotic AHA-1 expression from 
this fusion construct is still fully capable of rescuing the aha-1 mutants. 
AHA-1 can form a homodimer in vitro. However, at least in some C. elegans cell 
types, co-expression of a dimerization partner is required for efficient nuclear localization of 
AHA-1. In hif-l mutants, AHA-1 is not efficiently nuclear localized in the intestinal nuclei 
(Jiang et al., 2001). However, low levels of AHA-1 homodimers in the intestinal nuclei may 
be sufficient to execute developmental functions. The cky-1 \aha-l rescued worms will allow 
for further examination of the possible function of aha-1 homodimers by carefully analyzing 
other potential phenotypes of the rescued animals. 
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FIGURE LEGENDS 
Figure 1. aha-1 genomic structure and its mutant alleles. A. aha-1 corresponds to the 
genomic sequence for C25Al.ll. The exons are represented by black boxes. B. aha-l(ct383) 
is a Tel insertion allele that contains a Tel transposon in the 6th intron. The Tel insertion is 
indicated by a reverse triangle. C and D. aha-1 deletion alleles isolated as described in 
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materials and methods. iaOl is a 2.4 kb deletion which deleted most of the aha-1 coding 
region. ia02 is a 1.4 kb deletion which deleted part of exon 3, exon 4-6, also retained part of 
Tel sequence (281 bp Tel fragment is indicated by gray box). The start and stop codon of the 
transcripts is marked. 
Figure 2 Ink feeding assays. A. Wild type animals after feeding ink. Ink particles are 
abundant in the gut lumen. B. The "stuffed" pharynx of aha-1 mutants. Ink and bacteria are 
lodged in the pharynx and are undetectable in the gut lumen. C. Quantitation of the aha-I 
mutant feeding defects, aha-1 mutants are assayed 24, 36 and 48 hrs after hatching. Data are 
the average of three independent experiments ± SD. 
Figure 3 T01D3.2:GFP reporter expression pattern. A &B. In 1.5-fold embryo, 
T01D3.2:GFP reporter is expressed in 4 cells in the head. Two cells on the left side of the 
embryo are shown here. One cell is extending an axon (indicated by arrowheads), and the 
other is round and dying (indicated by arrows). B. Normarski image of A. C. After hatching, 
GFP is observed in a pair of neurons (AVHR&L). D. Illustration of C. GFP-expressing 
neurons are indicated by black ovals. Axon tracts are represented by thick or dotted lines. 
Figure 4 cky-1 reporter expression pattern. A. cky-1 fusion constructs. pR15 is the cky-1 :gfp 
reporter, which contains a Sal I-Bgl II fragment from cosmid C15C8 fused with GFP. In 
pHJ32, a Sal I-Sac I fragment containing the cky-1 upstream region is fused with the 
complete aha-1 genomic region. Black boxes, cky-1 exons; green box, GFP coding region; 
red boxes, aha-1 exons. B-F. cky-1 reporter pR15 expression pattern. B. GFP expression is 
observed in the pharynx primordium at 2-fold embryonic stage. D. In third stage larvae, 
expression is observed in several cell types in the pharynx including: el, e2 and e3, epithelial 
cells; ml-8, muscle cells; vpi, pharyngeal intestinal valve cells; mc, marginal cells and g2, 
gland cells. E. GFP expression pattern in the terminal bulb. G. 10H8 in situ immunostaining 
of the iaOl mutants rescued by pHJ32. C, F and H are the Normarski images of B, E and G. 
Asterisks indicate GFP-expressing cells outside of the pharynx. 
60 
Figure 5 Immunolocalization of AHA-1 using the monoclonal antibody 10H8. A. AHA-1 is 
present in the nuclei of a subset of pharyngeal cells. A second stage larva is shown here. The 
staining cells (indicated by arrows) in this focal plane include e2, epithelial cell; ml, m2, m5-
m8, muscle cells; mc, marginal cell and vpi, pharyngeal intestinal valve cell. C. AHA-1 
expression is also detected in the developing oocyte nuclei. Arrows indicate the positions of 
oocyte nuclei. B and D. DAPI staining of A and C. 
Figure 6 AHA-1 forms homodimers and heterodimers with CKY-1. A. Alignment of the 
bHLH domains of cky-1 and ahr-1 family. Accession no. are CKY-1, AF370361. AHR-1, 
AF039539570. h AHR, Homo sapiens AHR, P35869 and mAHR, Mus musculus AHR 
A46266. XM_100570 is a human predicted open reading frame (ORF), BB623011 and 
BB594112 are two murine ESTs (expressed sequence tags) that are expressed in brain tissues. 
B. CKY-1 binds AHA-1. CKY-1 and AHA-1 were expressed in rabbit reticulocyte lysates in 
the presence of [^methionine (lanes 1 and 2), subjected to immunoprecipitation with an 
AHA-l-specific antibody (IP, lanes 3-5). The antibody immunoprecipitates AHA-1 (lane 3), 
but not CKY-1 (lane 4). When AHA-1 and CKY-1 are coincubated, the antibody pulls down 
both proteins (lane 5). C and D. Gel mobility-shift assays for DNA binding of the AHA-
1:CKY-1 heterodimer and the AHA-1 homodimer. AHA-1 and CKY-1 were expressed 
independently, and incubated with labeled XRE or AHA-lwt probes. Unlabeled specific 
competitors were added into some reactions. To create supershifts (SS), 1^1 of AHA-l-
specific monoclonal antibody 10H8 (m), or polyclonal antibody (p) or a non-specific 
monoclonal antibody control (C) were added to some reactions. The reaction mixes were 
analyzed by nondenaturing polyacrylamide gels. Arrows indicate shift bands. NS, non­
specific band. 
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CHAPTER 4 GENERAL CONCLUSIONS 
SUMMARY 
In this dissertation, I use both genetic and biochemical methods to analyze the 
function of bHLH-PAS proteins in C. elegans. Major findings include: 1) The C. elegans 
genome encodes 5 bHLH-PAS proteins, and their unique expression patterns are revealed by 
either GFP/LacZ reporters or in situ immunostaining. 2) The C. elegans bHLH-PAS gene hif-
1 encodes the homolog of mammalian HIFa and is required for adaptation to hypoxia. 3) The 
C. elegans homolog of ARNT, aha-1, has an essential function. Phenotypic analyses and 
expression studies suggest that AHA-1 forms a dimer with CKY-1, and the complex has an 
essential role in pharyngeal function. 4) C. elegans CKY-1 likely represents a new bHLH-
PAS subfamily that dimerizes with members of the ARNT subfamily. 
The C. elegans genome encodes 5 bHLH-PAS proteins 
Blast searches for sequences similar to the mammalian ARNT PAS domain identified 
5 bHLH-PAS genes in C. elegans (Chapter 2). In a previous study, molecular and 
biochemical criteria were used to show that two of them, aha-1 and ahr-1, are the orthologs 
of mammalian AHR and ARNT (1). We generated reporter constructs for all 5 bHLH-PAS 
genes, ahr-1 GFP and LacZ reporters are expressed in many neurons, and ahr-1 has a role in 
neuronal differentiation and migration (Qin and Powell-Coffman, manuscript in preparation). 
The aha-l:gfp reporter pHJ02 is broadly expressed (Chapter 2, Figure 4). This expression 
pattern is confirmed by immunostaining with the AHA-1-specific monoclonal antibody 10H8 
(Chapter 2, Figure 5 and Chapter 3, Figure 5). The pR 19 F38A6.3lhif-1 GFP reporter is 
ubiquitously expressed in all the somatic cells (Chapter 2, Figure 4). The pR15 C15C8.2/c£v-
1 GFP reporter is expressed mainly in the pharynx, starting at the 2-fold embryonic stage and 
persisting through later developmental stages. It is also expressed in 5-10 cells immediately 
outside of pharynx (Chapter 3, Figure 4). The pR14 T01D3.2 GFP reporter is expressed in 
the AVH intemeurons. It is also expressed in the A VH sister cells in the embryo, which later 
undergo apoptosis. 
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The protein sequences and their expression patterns enable us to formulate testable 
hypotheses about their functions. These data led to the identification of hif-1 as the functional 
homolog of mammalian HIFa (Chapter 2). These studies also identified CKY-1 as a 
potential new dimerization partner for AHA-1 (Chapter 3), and suggested an essential 
function for aha-1 in the pharynx (Chapter 3). 
hif-1 encodes the homolog of mammalian HIFa and is required for adaptations to 
hypoxia in C. elegans 
The protein sequence of HIF-1 is most similar with that of the mammalian HIFa 
subfamily (Chapter 2, Figure 1). The pR19 HIF-1 :GFP reporter directs ubiquitously GFP 
expression (Chapter 2, Figure 4). These data prompted us to hypothesize that hif-1 is the 
homolog of mammalian HIFa. We tested this hypothesis using both biochemical and genetic 
methods. There were three major findings. 1) HIF-1 :GFP fusion protein expression is 
increased in response to hypoxia, and it is quickly degraded upon re-oxygenation (Chapter 2, 
Figure 3). 2) Animals defective in hif-1 function fail to adapt to hypoxia. While most 
progeny of the wild type N2 survive to adulthood (94%) at 1% oxygen, only 24% of the 
progeny of /zz/-/mutants survive to adulthood (Chapter 2, Table 1). 3) Both in vitro and in 
vivo data indicate that HIF-1 forms a heterodimer with AHA-1. In vitro expressed HIF-1 is 
able to co-immunoprecipitate with AHA-1 (Chapter 2, Figure 2). AHA-1 immunostaining 
reveals that efficient nuclear localization of AHA-1 in intestinal cells is dependent on the 
function of hif-1 (Chapter 2, Figure 5). These data demonstrate that C. elegans hif-1 is the 
functional homolog of mammalian HIFa. 
Identification of hif-1 as the homolog of mammalian HIFa establishes a simple 
genetic system to study the complex hypoxia signaling pathway. C. elegans is a powerful 
model system for studying signal transduction pathways. Further genetic analysis of hif-1 and 
its interacting genes will likely reveal conserved mechanisms of hypoxia signaling. This is 
underscored by the results of a recent independent study of C. elegans hif-1 by Peter Ratcliffe 
and his colleagues (2). They also identified hif-1 as the homolog of mammalian HIFa. 
Furthermore, they identified a C. elegans VHL homolog, vhl-1 and isolated a vhl-1 mutant. 
HIF-1 expression is increased in the vhl-1 mutant in normoxic conditions. More importantly, 
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HIF-1 expression is also increased in egl-9 mutants. Thus, genetic analyses of hif-1 led to the 
identification of the first direct oxygen sensor, the C. elegans EGL-9 prolyl hydroxylase and 
its mammalian homologs PHDs (prolyl hydroxylase-domain). The strong evolutionary 
conservation of the hypoxia signaling pathway further testifies to the promise of the C. 
elegans genetics in studying complex pathways. 
Hypoxia-inducible factor-1 is involved in the physiopathology of various human 
diseases (3). Answers to many questions about hypoxia signaling still remain elusive. Are 
asparaginyl/prolyl hydroxylases the only oxygen sensors for hypoxia responses? How can 
hypoxia responses be effectively inhibited or enhanced in vivo? A more thorough 
understanding of the hypoxia signaling pathways will enable us to find better treatments for 
diseases related to hypoxia such as heart attack, stroke and cancer. 
To gain insights to these questions, another student in the laboratory, Chuan Shen 
initiated a study to identify downstream targets of HIF-1 in C. elegans using DNA 
microarray technologies. One goal of the study to is to identify in vivo target genes of the C. 
elegans hypoxia-inducible factor complex AHA-l/HIF-1. This will allow the construction of 
hypoxia-responsive reporter genes that can be used to monitor the activity of hypoxia 
signaling in C. elegans. Additionally, they will enable both traditional forward genetic 
methods and functional genomics tools (such as systemic RNAi) to identify other regulators 
of hypoxia signaling. 
C. elegans is also a very suitable model organism for drug discoveries (4). egl-9 was 
originally identified as a locus that once mutated, confers the resistance to the paralysis 
caused by Pseudomonas aeruginosa (5). Subsequently, EGL-9 was shown to modify HIF-1 
in an oxygen-dependent manner (2). The toxicity of P. aeruginosa is due in part to hydrogen 
cyanide (HCN) production (6). It is not yet known whether HIF-1 over-expression is 
sufficient to protect worms from HCN. If true, this offers an opportunity to use C. elegans to 
screen for chemicals that will also confer resistance to HCN. Those chemicals will be 
candidates for specific inhibitors of the prolyl hydroxylase involved in hypoxia signaling. 
AHA-1 is able to dimerize with multiple bHLH-PAS proteins and CKY-1 may represent a 
new bHLH-PAS subfamily that interacts with ARNT 
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Results presented in this dissertation also confirm that AHA-1, like its homologs in 
mammals and flies, is able to dimerize with multiple bHLH-PAS proteins (Figure 1). AHA-1 
interacts with AHR-1 to form a complex that is similar to the mammalian AHR/ARNT 
heterodimer (1). AHA-1 is also able to form heterodimers with HIF-1 (Chapter 2, Figure 2) 
and CKY-1 (Chapter 3, Figure 6B&C). T01D3.2 expression is low in rabbit reticulocyte 
lysates, and this has precluded assays for interaction (CO-IP) with AHA-1. Whether it is able 
to interact with AHA-1 needs to be further tested. Shu Wu has shown that AHA-1 also forms 
a homodimer and binds to the class B E-box (Chapter 3, Figure 6). 
Consistent with aha-1's role as a common dimerization partner for other bHLH-PAS 
proteins, aha-1 mutants exhibit multiple defects. C. elegans aha-1 has an essential function 
during larval development (Chapter 3). Arrested larvae also have neuronal defects that are 
similar to those exhibited by ahr-1 mutants (Figure 2). It will be interesting to test whether 
the cky-1-.aha-1 rescued mosaic animals are sensitive to hypoxia treatment as the hypoxia 
signaling model (C. elegans HIF-1/AHA-1= mammalian HIFa/ARNT) predicts. 
CKY-1 is a new bHLH-PAS protein that is able to dimerize with AHA-1. Blast 
searches identified 3 mammalian homologs, including a predicted human open reading frame 
(ORF) and two murine ESTs. The 5' sequences of the two murine ESTs are different, 
suggesting that there are at least two mouse CKY-1 homologs. Their bHLH domains are 
highly homologous (Chapter 3, Figure 6A). Thus, CKY-1 may represent a new bHLH-PAS 
protein subfamily that is able to form heterodimers with ARNT. 
C. elegans aha-1 has an essential role during larval development 
Mutants that lack aha-1 function are larval lethal, and the phenotype is completely 
penetrant. Phenotypic analysis of the aha-1 mutants suggested that they are defective in 
pharynx function. The arrested larvae have pale intestines, similar to the starved animals. The 
terminally arrested mutant animals have a "stuffed" pharynx phenotype (Chapter 3, Figure 2). 
The ink particle-feeding assay confirmed that aha-1 mutants feed poorly. After feeding ink 
particles for 20 minutes, only about 40% of the mutant animals contain ink in their intestines, 
while for wild type N2, over 97% of them do (Chapter 3, Figure 2). A cky-1 :aha-l fusion, 
pHJ32, in which cky-1 promoter was placed upstream of the aha-1 coding sequence, 
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T01D3.2 
Pharyngeal function? 
Hypoxic response Neuronal development 
Figure 1 Model for the functions of C. elegans bHLH-PAS proteins. C. elegans genome 
encodes 5 bHLH-PAS genes, aha-1 is the C. elegans homolog of mammalian ARNT. 
AHA-1 is able to dimerize with multiple bHLH-PAS proteins. Its dimerization partners 
include: mammalian AHR homolog AHR-1. which mediates neuronal development 
(Powell-Coffman 1998 and Qin and Powell-Coffman, manuscript in preparation), 
mammalian HIFa homolog HIF-1, which mediates the hypoxic response (Chapter 2) and 
a new bHLH-PAS protein CKY-1, which has a possible role in pharyngeal function 
(Chapter 3). AHA-1 also forms homodimers in vitro. The function of the homodimers is 
unclear (Chapter 3). Whether AHA-1 interacts with T01D3.2 is also unclear. 
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Figure 2 SDQR migration defects in ahr-l and aAa-Z-defective animals. A-C Photographs of 
neuronal cell bodies and axons along the right anterior body wall. A pan-neuronal marker unc-
119:gfp were used to reveal the position of the cell bodies and axons. SDQR cell body and axon 
are indicated by asterisks and arrowheads respectively. A. The position of SDQR cell body and 
axon in wild-type animals. SDQR axon migrates dorsally from the cell body at the ALMR 
associated nerve to the dorsal sublateral nerve where it turns anteriorly. B and C. SDQR 
migration in ahr-l-defective (B) and aAti-/-defective (Q animals. SDQR is positioned ventrally 
and its axons migrate laterally to the anterior in both ahr-1 and aha-1 mutants. D and E. 
Illustration of A and B/C respectively. 
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efficiently rescued the aha-1 mutants to viability. 10H8 immunostaining of the rescued 
animals demonstrated that AHA-1 is mainly detected in the pharynx and a pair of phasmid 
neurons in the tail (Chapter 3, Figure 4). 
The larval lethal phenotype of aha-1 mutants can be explained by two non-exclusive 
models: aha-1 interacts with cky-1 and the heterodimer mediates an essential pharyngeal 
function. Alternatively aha-1 has an essential function as a homodimer in c£v-/-expressing 
cells. I prefer the heterodimer model for the following reasons. 1. AHA-1 forms a 
heterodimer with CKY-1 in vitro, and AHA-1 is nuclear localized in the subset of pharyngeal 
cells that express the CKY-1 :GFP reporter pR15. 2. Expressing aha-1 from the cky-1 
promoter rescued the aha-1 larval arrest phenotype. 3. The "stuffed" pharynx phenotype of 
aha-1 mutants is very similar to that of pha-4 temperature-sensitive mutants (7). PHA-4 
controls both the early and later stages of pharynx development and is required for the 
expression of many pharyngeal genes even after the pharynx has formed (7). Multiple PHA-4 
binding sites exist in the cky-1 promoter. PHA-4 may directly control cky-1 expression to 
regulate AHA-l/CKY-l heterodimer activity in the pharynx. If the heterodimer model is 
correct, then we expect the cky-1 loss-of-function will result in larval arrest. Wild type 
animals treated with cky-1 dsRNA did not reveal any embryonic or postembryonic defects. 
However this data may not be informative due to the inherent problems with the RNAi 
technique (8). Resolution of the problem will require genetic analysis of cky-1 function, 
achieved by generating a mutation in this gene using reverse genetic methods. 
It is worth noting that the cky-1 :aha-l fusion is also expressed in a pair of phasmid 
neurons and a couple of cells immediately outside of the pharynx. It is formally possible that 
the expression of aha-1 in these cells rescued the mutant phenotype. This could be tested 
using known promoters to direct pharyngeal specific expression of aha-1 (such as the 
pharyngeal muscle specific myo-2 promoter (9)). We do not yet understand the pharyngeal 
functions of aha-1 at the cellular level. However, promoters that direct expression in subsets 
of pharyngeal cells could be used to refine the cellular requirement of aha-1 in the pharynx. 
The promoters of the pharyngeal genes described by Gaudet et al. (2002) could provide 
valuable reagents for this experiment (7). 
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The regulation of cky-1 expression in the pharynx, especially the possibility that 
PHA-4 may directly regulate cky-1 expression can be analyzed by promoter truncation, 
combined with site-specific mutagenesis to mutate the potential PHA-4 binding sites on the 
cky-1 promoter, pha-4 temperature-sensitive mutants can be used to test whether PHA-4 
activity is required for the expression of cky-1:gfp reporter. 
REFERENCES 
1. Powell-Coffman, J. A., Bradfield, C. A. & Wood, W. B. (1998) Proc Natl Acad Sci USA 
95, 2844-9. 
2. Epstein, A. C., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., 
Mukhetji, M., Metzen, E., Wilson, M. IM Dhanda, A., et al. (2001) Cell 107,43-54. 
3. Semenza, G. L. (2000) Genes Dev 14, 1983-91. 
4. Link. E. M., Hardiman, G., Sluder, A. E., Johnson, C. D. & Liu, L. X. (2000) 
Pharmacogenomics 1, 203-17. 
5. Darby, C., Cosma, C. L., Thomas, J. H. & Manoil, C. (1999) Proc Natl Acad Sci USA 96, 
15202-7. 
6. Gallagher. L. A. & Manoil, C. (2001) J Bacteriol 183,6207-14. 
7. Gaudet, J. & Mango, S. E. (2002) Science 295, 821-5. 
8. Maine, E. M. (2001) Dev Biol 239, 177-89. 
9. Okkema, P. G., Harrison, S. W., Plunger, V., Aryana, A. & Fire, A. (1993) Genetics 135, 
385-404. 
80 
ACKNOWLEDGEMENTS 
I thank my supervisor Dr. Jo Anne Powell-Coffman for her insight and kindness. I thank 
members of my POS committee for their guidance through my career here at Iowa State. I 
want thank members of the Powell-Coffman lab and Becraft lab for their help. I thank Linda 
Wild for her assistance from day one and especially thank for her friendship. I thank Dr. 
Mark Hargrove and Dr. David Vleck for providing expertise and instruments to make the 
hypoxia experiments possible. Most importantly, I thank my wife Yan for her support 
through the years and my daughter Sabrina for just being herself. 
